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Abstract
Tamalin/GRAS-1 Connects Glutamate Receptor Activity to the Insulin/IGF Signaling Cascade to
Regulate Neuroprotection in a Nematode Model of Excitotoxicity
by
Ayesha Chowdhury
Advisor: Itzhak Mano, PhD
Brain ischemia is a major cause of debilitation and death in the United States.
Excitotoxicity, a condition that arises from the accumulation of glutamate (Glu) in the synapse that
leads to overactivation of Glu receptors (GluRs), is the major mechanism of neuronal damage in
brain ischemia / stroke. Although it is commonly acknowledged that over activation
of GluRs leads to neurodegeneration, it has been recently shown that even during excitotoxicity
Glu has a concurrent important role in regulating neuroprotection. GluR-activated transcription
factors seem to mediate this neuroprotection, but it remains unclear which signaling cascades and
transcription factors are regulated by GluRs in excitotoxicity. The Insulin/IGF signaling (IIS)
cascade is intensely studied for its role in regulating longevity and cell stress resistance. Using C.
elegans as a model, we have previously shown that the IIS cascade also regulates neuroprotection
in excitotoxicity in the nematode via its role in regulating transcription factor DAF-16. However,
a link between GluRs and the IIS cascade has not been fully investigated. We suggest
that GluRs may regulate the IIS cascade via complex formation at the postsynaptic density. Here
we identify the scaffolding protein Tamalin/GRAS-1 as a functional bridge linking the
communication between GluRs and IIS. We found Tamalin/GRAS-1 to be important in regulating
neuroprotection by working cell autonomously via the IIS cascade. We also show that there is a
physical link between GluRs and upstream regulation of the IIS cascade whose activity is
controlled by Tamalin/GRAS-1. These studies suggest a novel conduit of communication between
Glu and insulin signaling to regulate susceptibility to excitotoxic neurodegeneration.
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Chapter 1:
Introduction & Background
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1.1 Prevalent neurological diseases share common degenerative features
Neurodegeneration is a process of loss of neuronal function and neuronal cell death, with
dire consequences to both neurological and mental health. As the brain ages, arteriosclerosis and
blood clots are more common, reducing blood flow, and resulting in low oxygen flow through the
brain, causing brain ischemia. A progressive, diffuse, and gradual occlusion in the fine vasculature
causes vascular dementia (Iadecola 2013), while an acute occlusion of a major artery causes
ischemic stroke (Moskowitz et al. 2010). Furthermore, similar degenerative processes contribute
to the pathology of other neurological diseases such as Parkinson’s, Alzheimer’s and Huntington’s,
even if not accompanied by energy shortage (Mehta et al. 2013a; Zott et al. 2019; Yates 2019;
Lewerenz and Maher 2015). Instead, the common feature between ischemia and these diseases is
the dysregulation of glutamate (Glu), the major excitatory neurotransmitter in the mammalian
CNS, causing an abundance of Glu to accumulate in synaptic regions. This can lead to excessive
excitatory Glu signaling, which activates neurodegenerative pathways in a process called
excitotoxicity (Choi and Rothman 1990). Depending on the location of ischemic damage and the
severity of the neuronal loss, this can lead to problems in movement, mental function, or even
death. We look to study the process of Glu excitotoxicity as a whole and observe the
neuroprotective and neurodegenerative pathways associated with it, focusing on the common
features observed in a range of diseases.
Glu is involved in many different physiological functions such as learning and memory,
development, etc. (Derkach et al. 2007; Danbolt 2001). In contrast, pathologically low or high
levels of Glu have been associated with different neurological and psychiatric diseases (Timms et
al. 2013). For example, low levels of Glu activity is suspected in Schizophrenia (Timms et al.
2013). In contrast, in Alzheimer’s, Huntington’s, Parkinson’s and Amyotrophic Lateral Sclerosis
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(ALS), as well as in vascular dementia, high levels of Glu that cause excitotoxicity have been
shown to be a central factor in neurodegeneration (Mehta et al. 2013a; Lewerenz and Maher
2015) (as demonstrated in Figure 1). Therefore, by studying the mechanisms activated under
excitotoxicity, we will be able to work towards understanding a pathway involved in multiple
neurodegenerative and psychiatric disorders.
1.2 Glutamate is a major excitatory neurotransmitter in the mammalian Central
Nervous System (CNS)
The amino acid Glutamate is a major excitatory neurotransmitter that is carefully regulated
in order to maintain normal physiological communication and balance cell death and cell survival
signaling (Lai et al. 2014; Traynelis et al. 2010). The resting concentration of Glu in the synapse
cleft is maintained at about 25nM, by methods of reuptake and secondary-active removal via
transporters. As a physiological nutrient commonly found in all cells, intracellular concentration
of Glu at 10mM is maintained.
There are two main types of GluRs: ionotropic and metabotropic. Ionotropic receptors
are Glu-gated ion channels that include N-methyl-D-aspartate receptors (NMDARs) and nonNMDARs (α-amino-3-hydroxy-5-methylisoxazole-4-propionic

acid–receptor

(AMPAR),

and kainate receptors); metabotropic glutamate receptors (mGluRs) are G-protein coupled
receptors that activate second messengers and ion channels (Niswender and Conn 2010). Both
AMPARs and NMDARs are tetramers with each subunit containing a binding site for an amino
acid. The subunits of each receptor dictate receptor properties. NMDARs require two NR1
subunits, that contain the glycine binding site, and two NR2 subunits, subtypes A-D containing
the Glu binding sites. Some NR3 subunits exist as well. AMPARs consist of four types of subunits,
GluA1-A4 (Siegel 1999). Glu binds AMPARs and triggers Na+ conduction through the pore. The
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GluA2 subunit restricts Ca2+ permeability of the complex in many species (though C. elegans’
AMPARs are able to conduct Na+ and Ca2+ since their subunits miss the Ca2+ -restrictive Arg
residue in the pore-lining M2 hairpin loop).
Presynaptic cells package Glu into vesicles via vesicular glutamate transporter (vGluT).
The transporter is an H+-coupled antiporter that loads vesicles for Glu release. Presynaptic
excitation allows Ca2+ to enter the presynaptic terminal, causing Glu-filled vesicles to fuse at the
presynaptic terminal, release their content to the synaptic cleft, and allow Glu to bind to
postsynaptic GluRs. Glu binds AMPARs causing a confirmation change of the M2 segment of
each subunit allowing for Na+ influx. The influx causes depolarization of the postsynaptic cell that
may lead to an action potential. NMDARs require binding of both Glu and Glycine and sufficient
depolarization of the postsynaptic cell to remove the Mg2+ block to allow Ca2+ influx (Furukawa
et al. 2005). The influx of Ca2+ causes activation of several different cascades that can lead to an
action potential and long-term changes in neuronal activity.
1.3 Glutamate transporters facilitate the clearance of Glu from the synapse
Glu is actively removed from the synaptic cleft by Glutamate Transporters (GluTs) located
mostly on glia cells. The role of GluTs is of high importance in order to maintain low ambient
concentration of Glu in the synaptic cleft. The transporters must extract Glu out of the synapse
against a sharp concentration gradient down to an extracellular resting concentration of 25nM,
compared to an intracellular concentration of 10mM (Danbolt 2001). To execute this role, GluTs
are secondary active transporters that rely on a Na+/K+ ATPase pump to drive Glu intracellular
against its concentration gradient (Pavić et al. 2019) (Figure 1). Malfunction of the GluTs disrupt
the highly regulated concentration balance of Glu and can lead to significant pathological
conditions.
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1.4 Energy is required for proper Glu
Signaling
The majority of the Glu is
removed from the synapse via
GluT located on glia cells (Danbolt
2001;

Pavić

et

secondary-active
GluT work in

al.

2019); As
transporters,

conjunction

the Na+/K+ ATPase

with

pump: The

pump uses ATP to push 3 Na+ out and 2 K+ into the cell, reducing the Na+ concentration and
increasing K+ concentration inside the cytoplasm. This creates a strong driving force for the Na+ to
enter the cell and for K+ to move out. The strong driving force provided by the Na+ influx
and K+ outflux is used by GluTs to push Glu through the transporter against its concentration
gradient into the cell, reducing synaptic Glu concentrations to very low levels. However, under
circumstances of reduced energy or ATP, the Na+/K+ ATPase pump cannot function and
the Na+/K+ concentration gradients necessary for the GluT to function are reduced. The GluTs
bring in Glu by vacuuming it in with Na+. With the ATPase pump pushing out Na+ against its
gradient concentration, there is a large drive for Na+ to renter the cell. Normally GluTs are able to
bring in a single Glu as cotransport with three Na+ and in exchange for K+ and H+ (Pavić et al.
2019). Without the Na+/K+ gradients, the GluTs malfunction and are unable to remove Glu from
the synaptic region. The strong dependency of GluTs on the Na+ and K+ gradients make their
activity extremely sensitive to energy levels in the brain, so that even a slight reduction in the
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activity of the Na+/K+ ATPase causes a precipitous decline in the ability of GluTs to clear Glu,
making this system particularly sensitive to
ischemia.
1.5 Defining Excitotoxicity
Excitotoxicity
neurodegeneration

is

the

commonly

process
seen

in

of
many

neurodegenerative disorders including in conditions
following stroke. The process of excitotoxicity
arises from failure of Glu clearance from the
synaptic cleft (Choi and Rothman 1990).
The process can arise from many different situations. A common one is from the loss of
energy leading to malfunction of Na+/K+ ATPases pump (Zhang et al. 2019b). The loss of the
ATPases pump leads to malfunction of GluTs that are secondary active transporters relying on the
ATPases pump (Zhang et al. 2019b; Mehta et al. 2013b; Lai et al. 2014). Without the Na+
concentration gradient created by the pump, there is no longer a strong gradient of Na+ trying to
enter the cell. Thus, the GluT is no longer bringing in any Glu, and is unable to be remove it from
the synaptic cleft (Figure 2). With the accumulation of Glu in the synaptic cleft, there is
overactivation of the GluRs causing toxic levels of Ca2+ to enter the cell. The influx of Ca2+ leads
to the activation of several different cascades, including ones that may lead to neurodegeneration.
While a number of other transporters are also dependent on energy and the gradients produced by
the Na+/K+ ATPase, the effect of energy deprivation on the Glu system is highly unstable: any
molecule of Glu that remains in the synapse can now participate in the opening of GluRs and
trigger the influx of many Na+ and Ca2+ ions into the postsynaptic neuron. Therefore, the sensitivity
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of GluTs to energy levels in the brain and the catalytic effect of Glu on neuronal depolarization
and Ca2+ influx form the basis for the special sensitivity of the CNS to ischemia.
1.6 Excitotoxicity is the leading mechanism of Neurodegeneration in Stroke and other
neurological disorders
Stroke is typically caused by a blood clot that prevents the flow of blood and energy to
the affected brain area. The lack of energy in turn leads to excitotoxic neurodegeneration (Choi
and Rothman 1990; Zott et al. 2019; Zhao et al. 2019; Zhang et al. 2019b; Zhang et al. 2019a).
The severity of the condition depends upon the timeframe in which that patient receives
treatment (Moskowitz et al. 2010). Since the event of excitotoxicity is not singular but a broad
effect, there are many different pathways that become activated and several methods of
neurodegeneration that are activated. The intensity and severity of excitotoxicity increases with
exposure, or lack of treatment (Lee et al. 1999; Dirnagl et al. 1999). The pathways affected by
excitotoxicity also expands with duration of exposure, thus there are waves of neurodegeneration
that can be seen occurring via different methods.
1.7 Apoptosis mostly found in the penumbra region
There are three major forms of cell death and all have been suggested to participate in
neurodegeneration following brain ischemia (Lipton 1999; Fricker et al. 2018): apoptosis (type I
cell death), autophagic (type II), and necrosis (type III). The three types can be executed through
distinct and overlapping signaling pathways. The characteristics of Apoptosis follow cell
shrinkage, membrane blebbing and condensation of the chromatin (Kerr et al. 1972; Tower
2015; Pistritto et al. 2016; Sen 1992; Fleisher 1997; Bredesen 1995). Apoptosis is triggered by
two major signaling pathways: the mitochondrial pathway (intrinsic) and the death receptor
(DRs) (extrinsic) and carried out by proteases known as caspases (Pistritto et al. 2016; Tower
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2015). The mitochondrial pathway, controlled by the Bcl2 protein family, is activated by loss of
integrity of the mitochondrial outer membrane, triggering release of pro-apoptotic factors into
the cytosol, and inducing the assembly of caspase-activation complex: the apoptosome.
Apoptosis via the DRs (Fas and Trail receptor) occurs upon ligand binding the DRs and directly
recruiting a caspase-activation complex (Green and Llambi 2015). Apoptosis has been the cell
death process most studied in excitotoxicity and neuropsychiatric disorder (Olney 2003; Elmore
2007; Diamantis et al. 2008). However, different mechanisms of cell death may dominate in
different phases and locations, depending on the type and intensity of insult the neurons are
exposed to. In conditions following acute brain ischemia, two important areas can be
distinguished, with a gradual transition in between: the ischemic core (or stroke center) and the
ischemic penumbra (or stroke periphery). The core faces abrupt loss of blood flow, resulting in
irreversible neuronal injury and cell death (mostly by necrosis, see below). The penumbra on the
other hand shows apoptosis after several hours or days (Radak et al. 2017; Uzdensky 2019;
Broughton et al. 2009). However, the balance between the necrotic core and apoptotic penumbra
areas is also changing with time. Indeed, the area of initial necrosis might spread with time
during secondary injury, due to a moving front of necrosis (Borgens and Liu-Snyder 2012)
following spreading peri‐infarct depolarization (Dirnagl et al. 1999; Doyle et al. 2008; Lauritzen
et al. 2011).
1.8 Autophagy can serve as a pro-death or pro-survival process
Autophagy is activated under metabolic stress, important for removal of damaged
organelles, protein aggregates, and infecting organisms (Green and Llambi 2015; Guo et al. 2018;
Mizushima and Komatsu 2011; Mizushima et al. 2008). Autophagy is a survival process that
culminates in the formation of a double membrane structure: the autophagosome. The process is
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regulated by multiple autophagy-related (ATG) proteins (Mizushima et al. 2008; Green and
Llambi 2015). Autophagy can consist of random engulfment of bulk cytosol during starvation or
be a selective process and remove specific subcellular structures in the absence of metabolic stress
(Dupont et al. 2011; Green and Llambi 2015; Mizushima et al. 2008). Selective autophagy is
conferred by adaptor proteins that tether the target structure to the nascent phagophore. Through
this process, cells are able to remove aggregates formed by unfolded proteins or defective
organelles (i.e. damaged mitochondria) and promote cell survival (Tan et al. 2014; Menzies et al.
2015; Menzies et al. 2017; Kim et al. 2017; Guo et al. 2018).
1.9 Necrosis is the main form of cell death in ischemia
Necrosis can encompass a wide variety of cell death processes but is signified by ATP
depletion, cytoplasmic and organelle swelling, and loss of organelle and plasma membrane
integrity (Green and Llambi 2015; Berghe et al. 2014; Bae et al. 2014; Wallach et al. 2016; Tower
2015; Galluzzi et al. 2014). Necrosis can occur from extensive damage from physicochemical
stress causing cell death to occur quickly due to direct effects of the stress on the cell (Green and
Llambi 2015). Morphologically, Necrosis can be difficult to distinguish from apoptotic cell death.
The molecular details of Necrotic degeneration are not completely understood. Though seemingly
unregulated, necrosis is often a regulated process (Berghe et al. 2014; Galluzzi et al. 2014). One
subtype of regulated necrosis involves also components of the apoptotic pathway and is called
necroptosis (Vandenabeele et al. 2010; Galluzzi et al. 2017): the process is typically initiated by
receptor interacting protein 1 (RIPK1) and RIPK3 interaction to form a necrosis signaling
complex, called necrosome (Green and Llambi 2015; Fang et al. 2016; Berghe et al. 2014). A
common hazard shared among all necrotic cell death mechanisms is that the dying cell can release
its content to the surrounding milieu, including multiple pro-inflammatory factors (i.e. high
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mobility group protein B1 proteins) to activate inflammatory response (Hanus et al. 2013). Since
these molecular initiators contribute to other cellular functions and are not specific to cell death,
biochemical markers are not always available to discriminate necrosis and apoptosis (Berghe et al.
2014). Inhibition of caspases and RIPK independently showed that necrosis, not apoptosis, is a
major type of cell death in retinal pigment epithelium cells in response to oxidative stress (Hanus
et al. 2013). Necrosis is also the primary form of cell death seen in the ischemic core (Ankarcrona
et al. 1995; Lee et al. 1999; Dirnagl et al. 1999). Furthermore, the intense depolarization and the
release of cytoplasmic Glu from ruptured necrotic neurons causes increases Glu concentration
around the dying neuron, depolarizing its neighbors, causing bystander neurodegeneration,
propagating the damage and expanding the area of injury by a moving front of necrosis (Borgens
and Liu-Snyder 2012).
1.10

Glutamate Excitotoxicity involves both death-promoting and pro-survival

effects
Accumulation

of Glu over-activates

the

post-synaptic GluRs, allowing

large

amounts of Ca2+ to enter the neuron (Lai et al. 2014; Mano and Driscoll 2009), and activate many
different cascades and pathways including those signaling neuronal death (Lai et al. 2014) in
excitotoxicity. Surrounding neurons can also be affected either from spill-over from the affected
synapse or release of inflammatory peptides from dying neuron, causing more neurodegeneration.
Although a number of additional molecular pathways have been suggested to mediate
neurodegeneration in brain ischemia, the preponderance of evidence supports that
neurodegeneration is mainly by excitotoxicity, though the downstream mechanisms causing cell
death following depolarization and Ca2+ influx through GluRs remain highly controversial (Lai et
al. 2014; Mehta et al. 2007; Szydlowska and Tymianski 2010). This state of affairs facilitates an
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intense search for ways to block excitotoxicity, possibly at the level of GluR
antagonism. However, surprisingly, complete block of GluRs following ischemic stroke is
counterproductive, since clinical trials showed that it is ineffective, while sometimes it
even increased severity of patients’ conditions compared to placebo controls (Davis et al. 2000;
Albers et al. 2001). This counterintuitive effect suggests that in addition to their death-promoting
role, GluRs have a neuroprotective role. The proposed concurrent neuroprotective role of GluRs
was further supported by parallel pre-clinical studies that also showed that ”prophylactic”
activation of Glu synapses that were later exposed to a standard excitotoxic insult enhance
neuronal survival and was thus neuroprotective (Ikonomidou and Turski 2002). A protective effect
of ischemic preconditioning is a phenomenon observed in a number of tissues and involve a
number of mechanisms (Yellon and Hausenloy 2005). However, neuronal ischemic
preconditioning seems to depend specifically on transcription factors that are otherwise regulated
by

synaptic

activity

(Ikonomidou and Turski
2002; Dirnagl et al. 1999;
Kitagawa 2007; Dirnagl
et al. 2009; Iadecola and
Anrather 2011; Kitagawa
2012), and are therefore
triggered

by

signaling cascades.
Figure 3: GluRs can interact with an orchestra of proteins and kinases on the PSD.
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Glu

The nature of fate-determining signaling cascades that are triggered by GluRs is
determined by the proteins that co-assemble with GluRs in the Post Synaptic Density (PSD), a
large postsynaptic assembly of membrane proteins, scaffolding proteins, enzymes, and signaling
proteins that is so dense that it becomes visible in dendritic spines under electron-microscopy
(Kennedy 2000; Sheng and Kim 2002; Sheng and Kim 2011; Zeng et al. 2018) (Figure 3). Through
these complex connections, GluRs are able to have multiple effects at once. Recent studies have
shown that certain GluR subunits can facilitate protection from excitotoxicity (Yin et al. 2019;
Maiolino et al. 2019). Therefore, it is likely that GluRs regulation of downstream effectors are able
to mediate neuroprotection under excitotoxic conditions, possibly at a more gradual level.
1.11

CREB is a transcription factor in the nervous system known for its

importance in synaptic plasticity
CREB (Ca2+/cAMP Response Element Binding Protein) is a transcription factor activated
by Ca2+/cAMP (Sheng et al. 1990), and a key activity-dependent transcription factor that is
involved in both synaptic plasticity (Kandel 2001; Deisseroth et al. 2003; Carlezon et al. 2005;
Flavell and Greenberg 2008; Cohen and Greenberg 2008; Yap and Greenberg 2018) and
neuroprotection (Kitagawa 2007; Lee et al. 2009; Sakamoto et al. 2011; Bell et al. 2013; Lai et al.
2014). CREB consists of several domains including the crucial leucine zipper (bZip) domain that
allows for DNA binding and dimerization. CREB is a very well-studied transcription factor, thus
its roles and methods of activation are well known. Synaptic plasticity, long term potentiation
(LTP), learning and memory are some of the heavily studied roles of CREB (Kandel 2001).
Synaptic activity studied on Aplysia was the first study to link the activity of CREB to long term
synaptic changes. CREB was later found to facilitate mammalian LTP (Dash et al. 1990; Kandel
2001).
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1.12

CREB is an important mediator of neuroprotection in excitotoxic conditions

Studies on excitotoxicity revealed the importance of CREB regulation in the facilitation of
neuroprotection. Using hypoxia as a method to study excitotoxicity, Walton et al. (1999) found
that sever conditions induced necrosis, while moderate hypoxia caused apoptosis (Walton et al.
1999). They also found elevated levels of the phosphorylated form P-CREB and BDNF in the
sever conditions, suggesting their importance in regulating neuroprotection (Walton et al. 1999;
Walton and Dragunow 2000). Recent studies of CREB in excitotoxic conditions have elucidated
the pathway through which CREB is active in excitotoxicity to facilitate neuroprotection. One such
study found neuronal survival following oxygen-glucose deprivation (OGD) is regulated by SIK2
dependent CREB activity (Sasaki et al. 2011).
1.13

Stimulation of multiple pathways may be required for specific activation of

a transcriptional neuroprotective program by glutamate receptors
CREB is a transcription factor that promotes one of the pathways for neuroprotection.
CREB is indirectly activated by glutamate receptors from the influx of calcium ions (Sheng et al.
1990). However, over 4,000 genes can be regulated by CREB (Zhang et al. 2005; Impey et al.
2004) in response to hundreds of different stimuli (Johannessen et al. 2004) in many cell types.
Therefore, it is likely that the
glutamate-triggered neuroprotective
transcriptional program requires a
more specific set of triggers than
the non-distinct activation of one
promiscuous transcription factor.
Figure 4: Schematic of multiple transcription factors
activating a single gene. Pearson Education 2008.
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Specificity may instead come from the specific combination of signaling cascades
stimulated by excitotoxicity, and an ensemble of transcription factors that they regulate (Figure
4). The FoxO forkhead transcription factor (which is usually regulated by the Insulin/IGF-1
Signaling cascade) is a key cell-death-regulating factor, though primarily it has been suggested to
promote apoptosis (Eijkelenboom and Burgering 2013).
However, recent studies have shown that FoxO may actually be facilitating neuronal
plasticity and neuroprotection (Cohen and Dillin 2008; Dillin and Cohen 2011; MojsilovicPetrovic et al. 2009; McLaughlin and Broihier 2018). Further investigation is needed to
evaluate how FoxO can be a neuroprotective effector under excitotoxicity.
1.14

The evolutionarily conserved Insulin/IGF-1 Signaling cascade
The Insulin/IGF-1 Signaling (IIS) cascade is a
pathway found to be involved in longevity and cell
stress resistance. The pathway starts with the IR/IGF-1
receptor that becomes activated by the binding of
insulin-like ligands (Insulin or IGF1) (Figure 5)
(Murphy 2006; Lin 1997; Christensen et al. 2006).
Receptor activation leads to activation of
phosphatidylinositol-4-5-biphoshate 3-kinase (PI3K)
(either directly, or through recruitment of insulin
receptor substrate IRS, not shown). PI3K then changes
the signaling lipid PIP2 to PIP3 (which can be reverted
Murphy 2006

back to PIP2 by the phosphatase PTEN). PIP3 recruits

several Ser/Thr kinases to the plasma membrane and activates kinases, including PDK-1, which
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is then brought up to the plasma membrane. PDK-1 then goes on to activate AKT, which is also
brought up to the membrane by PIP3. AKT then phosphorylates FoxO transcription factor and
inhibits the translocation of FoxO from the cytoplasm to the nucleus. The working of the IIS
cascade in nematodes will be further described below.
1.15

Possible connection between GluRs and the Insulin/IGF-1 Signaling (IIS)

cascade
As we come to consider the possibility that the IIS cascade and FoxO might regulate
neuronal survival in excitotoxicity, it is interesting to examine the existing (yet sparse) evidence
that supports a connection between GluRs and the IIS cascade. Initial studies found that the IIS
cascade can regulate the level of GluR content of synapses, since insulin was able to accelerate
AMPAR endocytosis, causing long-term depression (LTD) in hippocampal CA1 neurons (Man et
al. 2000). Later studies showed that IIS-GluR signaling is not only from the IIS to GluRs, but is
also bidirectional: PI3K (the kinase that phosphorylates PIP2 the immediate mediator of signaling
from the Insulin Receptor) is activated in LTP (Sanna et al. 2002), LTD (Kim et al. 2011), and
excitotoxicity (Brennan-Minnella et al. 2013), causing it to associate with AMPAR at synapses
and increase trafficking of the PI3K-AMPAR complex to the cell surface (Man et al.
2003). Furthermore, more recent studies widen the concept of bidirectional IIS-GluR signaling,
showing that PTEN (a phosphatase that reverses the action on PI3K and another component of the
IIS cascade) also associates with the postsynaptic density complex (through PDZ domain proteins)
in response to GluR activation to regulate synaptic plasticity (Jurado et al. 2010; Arendt et al.
2014; Shabanzadeh et al. 2019; Knafo and Esteban 2017). These studies suggest that a connection
may exist between the insulin pathway and GluR in mammalian neurons.
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The main effect of IIS activation is to ultimately inhibit the transcription factor FoxO
(Dillin and Cohen 2011). Since FoxO is known to be a pro-apoptotic factor in a range of tissues,
cell types and scenarios (Dillin and Cohen 2011), IIS activation is regarded in the CNS studies
described above as neuroprotective (Lai et al. 2014; Hardingham and Bading 2010; Shabanzadeh
et al. 2019). However, this notion is in direct contradiction to the neuroprotective role of FoxO in
many other cases (Dillin and Cohen 2011). The complexity, redundancy, and extensive cross talk
in mammalian signaling cascades might therefore complicate the analysis of IIS/FoxO’s role in
excitotoxicity-specific transcriptional programs in neuroprotection. In order to further investigate
the pathways involved in neuroprotection we need a simple, conserved and easy-to-manipulate
model.
1.16

Caenorhabditis elegans as a Model for Analyzing Insulin/IGF-1 Signaling

Cascade
Caenorhabditis elegans are small non-parasitic nematodes that have been used as a model
organism since 1963 (Alexander et al. 2014; Brenner 2003; Kumar and Cakouros 2004). A
combination of characteristics and availability of research tools makes C. elegans a system of
choice in the analysis of complex signaling cascades in neuroscience. These include strong genetic,
molecular biology, cell biology, and neuroscience tools; low viability-requirements that allow even
severely affected mutants to survive and have progeny; a particularly detailed understanding of
behavior, circuits, neurons, and synapses that can be monitored by optogenetics in intact animals
(thanks to their transparency); and a treasure trove of freely available mutant strains and
reagents. C. elegans are also great genetic tools for isolating and characterizing specific genes and
pathways because signaling cascades are less intertwined and contain less redundant effectors than
the corresponding mammalian pathways, making them the ideal model for our study. Due to
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this simplicity and homology, C. elegans have been used to study many different
neurodegenerative disorders: Alzheimer’s, Parkinson’s, Huntington’s, etc. (Alexander et al.
2014). Many of the critical pathways are evolutionarily conserved in C. elegans, providing us a
simplified homologue to the human system and function, including the apoptotic pathway (Kumar
and Cakouros 2004) and Insulin/IGF signaling pathway (Engelman et al. 2006).
These advantages were highly instrumental in providing a detailed understanding of the
IIS cascade. As shown in figure 5 (adopted from Christensen et al. (Christensen et al. 2006)) the
IIS pathway was found to be astonishingly conserved between nematodes and mammals (Kenyon
2005). In C. elegans it includes the insulin receptor DAF-2, the PI3-kinase (PI3K) AGE-1, the PI3
phosphatase DAF-18 (a PTEN homolog, working in reverse to PI3K), the PIP3-dependent kinase
PDK-1, the protein kinase AKT-1 and the transcription factor DAF-16. Activation of the IIS
cascade leads to the phosphorylation of DAF-16, preventing it from entering the nucleus, thus
unable to function as a transcription factor. Inhibition of the IIS allows DAF-16 to freely enter the
nucleus and transcribe genes necessary for cell stress resistance and longevity. DAF-16 is a
homologue

to

the

mammalian FoxO fork-head neuronal transcription

factors

AFX,

FoxO3A/FKHRL1 and FoxO1/FKHR (Fukunaga and Shioda 2009). The role of DAF-16 was later
expanded from regulating animal longevity to also regulating cell resistance to a range of
challenges (e.g., accumulation of toxic aggregates), a property seen across neuronal cells (Cohen
and Dillin 2008; Kenyon 2005). In spite of the great conservation of IIS signaling cascade, some
controversy arose from the study of this pathway in cancer, where mutations in the IIS inhibitor
PTEN are tumorigenic because they over-activate the pathway and suppress an apoptosispromoting effect of FoxO. However, the IIS provide cell resistance to non-apoptotic insults,
thus, able to regulate cell stress resistance and longevity in mammals and nematodes (Salih and
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Brunet

2008).

The IIS pathway is

therefore studied

here

for

its

ability

to regulate neuroprotection; with this model system we will be able identify whether IIS is one
of the pathways through which GluRs mediate neuroprotection and identify core components
necessary for neuroprotection under excitotoxicity.
1.17

C. elegans exhibits a well-developed Glu function in central synapses

Glu is the main excitatory neurotransmitter in the worm’s computational synapses
(Brockie and Maricq 2006) and the core components of the GluR are conserved (Brockie et al.
2001a) in C. elegans, making it a great model system to study excitotoxicity. Like mammals, C.
elegans have ionotropic and metabotropic glutamate receptors. C. elegans have 8 non-NMDA
subunits (GLR-1 – GLR-8) similar to AMPA or Kainate subfamilies and 2 NMDA subunits
(NMR-1 and NMR-2) belonging to NR1 and NR2A subfamilies, respectively (Brockie and Maricq
2006). Four non-NMDA (glr-1, glr-2, glr-4 and glr-5) and 2 NMDA are widely expressed in the
head region of the worms in many of the command interneurons (AVA, AVB, AVD, AVE and
PVC) controlling movement (Brockie and Maricq 2006). glr-3 and glr-6 are expressed in RIA
neurons and glr-7 and glr-8 are in the pharyngeal nervous system (Brockie and Maricq 2006).
Osmotic avoidance response were found to require both NMDAR and non-NMDAR, while
mechanical stimuli only require non-NMDAR (Mellem et al. 2002). Behavioral assays with nose
touch and mobility lead to the discovery that the presence of GLR-1 in command interneurons is
necessary for proper backward movement (Mellem et al. 2002; Kaplan and Horvitz 1993; Hart et
al. 1995; Zheng et al. 1999). Comparison of C. elegans NMR-1 to mammalian NMDARs showed
conservation of the pore region. However, unlike mammals, C. elegans’ NMR-1 does not have
Mg2+ block. Moreover, they have a small (and probably less interactive) cytosolic tail, and they
are less widely expressed (or co-localized with AMPA-Rs) than mammalian NMDA-Rs (Brockie
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et al. 2001b; Burnashev et al. 1995; Hahn et al. 2011; Malenka and Nicoll 1999; Sheng and
Hoogenraad 2007; Choquet and Triller 2013). Amino acid sequence of rat AMPAR GluR1 and C.
elegans GLR-1 are mostly conserved; however, differences in pore domain in C. elegans allows
GLR-1 to conduct Ca2+ (Seeburg et al. 1998). Most behavioral assays of learning and memory
suggest that GLR-1, and not NMDA-Rs, are important for synaptic plasticity (Rose et al. 2003;
Rose 2005). Furthermore, KO of nmr-1;glr-2glr-1 ablated all Glu mediated currents in key
neurons such as AVA, but rescue of GLR-1 alone is able to significantly reestablish Glu mediated
current (Mellem et al. 2002). Thus, GLR-1 was established to be the prominent receptor in
maintaining Glu mediated current in key neurons. Later experiments showed that activation,
synaptic localization, and regulation of GLR-1 is affected by the interaction of its cytosolic tail
(Chang and Rongo 2005) with MINT2/LIN-10, CASK/LIN-2 (Chang and Rongo 2005; Rongo et
al. 1998; Grunwald and Kaplan 2003; Glodowski et al. 2005), MAGI-1 (Emtage et al. 2009),
CAMKII (determining glutamatergic synapse formation) (Rongo and Kaplan 1999), and Ubiquitin
(determining expression regulation) (Kowalski et al. 2011; Wang et al. 2008; Dahlberg and Juo
2014; Burbea et al. 2002). In addition to auxiliary subunits such as Stargazin/TRAP, which were
found in the nematode following the characterization of their homologs in mammals (Wang et al.
2008), other critical & conserved auxiliary subunits such as SOL-1 (Brockie and Maricq 2006)
and SOL-2 (Wang et al. 2012) were first identified in C. elegans by an unbiased genetic screen. In
addition to the mammalian-like excitatory ionotropic GluRs, the nematode also has mammalianlike metabotropic GluRs (mGluRs, (Dillon et al. 2015)) and invertebrate-like inhibitory ionotropic
GluR (Wolstenholme 2012).
C.

elegans express

6 GluTs (GLT-1,

GLT-3–GLT-7)

highly

homologous

to

mammalian GluTs (Mano et al. 2007). GLT-1 and GLT-4 are more proximal to glutamatergic
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synapses, as they are expressed on glia, hypodermis, and head muscles or on presynaptic neurons,
respectively. GLT-3, GLT-6 and GLT-7 are more distal from the synapses, located in excretory
canal cells (Mano et al. 2007). Despite their location, behavioral and physiological experiments
established that the distal GluTs contributed more significantly to Glu clearance, particularly
GLT-3 (Mano et al. 2007).
Put together, it becomes clear that in spite of some differences (such as the emphasis in the
nematode on AMPA-Rs as providing Ca2+ permeability and controlling synaptic plasticity), the
nematode system of Glu signaling is highly homologous to the mammalian one and can be used
(as seen in examples like SOL-1 or regulation by ubiquination) to gain previously-unknown
mechanistic insights that are conserved to mammalian Glu signaling.
1.18

We have generated a model of excitotoxicity in C. elegans
To expand the use of nematode modeling
of Glu signaling,

we

created

a C.

elegans

excitotoxicity model that mimics key aspects of
mammalian excitotoxic neurodegeneration (Mano et
al. 2007; Mano and Driscoll 2009) (Figure 6). We
combined a deletion of glt-3 (Δglt-3 Mano et al.
2007) with nuIs5 (Berger et al.), a transgenic
construct that expresses a hyperactive Gαs in neurons
postsynaptic to central Glu synapses (as it is expressed, along with a gfp marker, under glr1 promoter, using the integrated transgenic construct labeled nuIs5). This combination generated
high level of necrotic cell death, which we are able to visualize as “bubbles” or vacuole-like
structures using Nomarski DIC optics in live worms. The peak level of “bubbles” is at L3 stage,
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when GluRs become fully functional. Levels of “bubbles” is seen to decrease after L4 and adult
stage since most of the dying neurons are cleared by corpse engulfment. Although excitotoxic
neurodegeneration in mammals is mostly mediated by NMDAR, most of the neurodegeneration
we see can be linked with GLR-1 activity as GLR-1 (but not NMR-1) is necessary for the
neurodegeneration we see. Furthermore, all the neurons dying seem to be GLR-1-expressing
neurons (as the vast majority of swollen neurons are labeled with Pglr-1::gfp ; the few dying neurons
that do not show clear GFP signal exhibit advanced neurodegeneration in locations that are in line
with those of GLR-1–expressing neurons, suggesting that in these neurons the GFP protein has
degraded too much for fluorescence to be visible). However, specific subgroups of GLR-1 –
expressing neurons that are more susceptible to degeneration are currently being examined. Data
obtained by other people in the lab suggest that most deaths occur in neurons that are heavily
innervated by GLR-1-containing, but not NMR-1-containing synapses (although other, NMR-1expressing neurons do express nuIs5 and are at-risk of dying) (Feldmann et al., 2019). It is still not
known

how

the

neurodegeneration

we

see

is

induced

under

excitotoxicity, nor

the pathways activated by GluRs that are involved in this process. We particularly do not know
how neuroprotection is regulated by GluRs and if IIS signaling is involved in such
neuroprotection.
1.19

Nematode excitotoxicity is modulated by the IIS cascade

We started our exploration of the possible role of GluR-regulation of IIS signaling in
neuroprotection with previous insights on IIS mechanisms. We already know that under proper
conditions, the IIS pathway regulates longevity and cell stress resistance by regulating the
phosphorylation and therefore nuclear vs cytoplasmic localization of DAF-16 (Ogg et al. 1997;
Hwangbo et al. 2004; Furukawa-Hibi et al. 2002; Chen et al. 2015). To test if IIS activity
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and FoxO/DAF-16 regulates susceptibility to excitotoxicity in both nematodes and mammals, we
collaborated with the Kalb lab (Mojsilovic-Petrovic et al. 2009). We found that a mutation in age1 reduced

the

extent

of

excitotoxic

neurodegeneration

in

the

worm. Treatment

with Psammaplysene A (PA), which prevents the phosphorylation of FoxO/DAF-16 by
sequestering it in the nucleus, significantly reduced neurodegeneration levels in both nematodes
and mammalian neurons (Mojsilovic-Petrovic et al. 2009). These studies establish the
neuroprotective role of FoxO/DAF-16 in excitotoxicity. Furthermore, we see the neuroprotective
effect is not mediated by other kinases of the IIS cascade (as suggested in some mammalian studies
proposing that CREB is phosphorylated by Akt), since FoxO/DAF-16 translocation to the nucleus
is sufficient to induce neuroprotection.
A recent graduate student from
our

lab, Nazila Tehrani, addressed

contradicting proposals coming from
mammalian neurodegenerative research,
claiming that pharmacological inhibition
of PI3K/AGE-1 increased cell death
(Hardingham and Bading 2010; Dillin
and Cohen 2011). Using the same drug from the mammalian study to inhibit PI3Ks (Δglt3;nuIs5+LY294002) she found decreased levels of neurodegeneration compared to the
excitotoxicity strain (Δglt-3;nuIs5) (Tehrani et al. 2014). These results further supported that the
IIS pathway is able to regulate neuroprotection in the manner we described before: PI3K/AGE-1
and Akt/AKT-1 activity causes increased neurodegeneration, while FoxO/DAF-16 activity
increases neuroprotection (Figure 7). We suggest that the difference in results between most
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mammalian work and ours comes from the fact that the mammalian studies looked at Glu-induced
apoptosis, while we are looking at an apoptosis-independent excitotoxic necrosis in nematodes
(Tehrani et al. 2014) and mammalian spinal cultures (Mojsilovic-Petrovic et al. 2009). These
observations emphasize the notion that mammalian signaling cascades are very complex and
include multiple opposing effects, while the nematode model allow us to isolate components of
these effects and understand their mechanisms with more clarity.
We next asked about possible upstream regulatory mechanisms that determine the level of
activity of the IIS cascade. The Cytohesin complex was found to be a regulator of insulin signaling
in mammalian studies looking at metabolism in liver cells (Jackson et al. 2000; Kolanus 2007;
Donaldson and Jackson 2011). The complex is composed of 3 main proteins: Cytohesin/GRP-1,
ARF, and PIP5K/PPK-1; the IIS-core-enzyme PI3K/AGE-1 uses the substrate, PIP2, produced by
the complex. Tehrani et al. (2014) further found that inhibition of GRP-1 under excitotoxicity
(grp-1;Δglt-3;nuIs5) reduced levels of neurodegeneration (Tehrani et al. 2014). Furthermore,
epistasis

experiments

(grp-1;glt-3;nuIs5 +/-

LY294002)

showed

that

the

Cytohesin

complex operates in the same pathway as the IIS pathway (Tehrani et al. 2014). Tehrani et al.
(2014), therefore, establish the cytohesin complex as an upstream regulator of the IIS cascade.
Now we look to identify unclear regulators of the Cytohesin complex that might link to GluRs. A
possible lead on such a presumed connection comes from separate sets of mammalian
studies that showed the Cytohesin complex to interact with GluRs and insulin pathway via the
scaffolding protein Tamalin (Kitano et al. 2002; Attar and Santy 2013; Nevrivy et al. 2000).
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1.20

Tamalin/GRAS-1 interacts with both glutamate receptors and the Cytohesin

complex
Tamalin/GRAS-1 is a scaffolding protein that interacts with GluR-containing postsynaptic
complexes, it has a PDZ domain that binds either other PDZs, PDZ ligand sequence, or PIP2 in
the cell membrane (Kitano et al. 2002; Kitano et al. 2003; Sugi et al. 2007; Sugi et al. 2008) on
the amino-terminal half, and it interacts
with Cytohesin through a Leucine Zipper.
Furthermore, it also has a PDZ-ligand
domain on the C-terminal, so it can interact
with other copies of itself or with other
PDZ-domain proteins (Kitano et al. 2002).
The distinct protein-interacting domains of Tamalin are evolutionarily conserved (Kitano et al.
2003). As expected from its structure, Tamalin is able to form protein complexes with multiple
postsynaptic and protein-trafficking scaffold proteins (Kitano et al. 2003; Ogawa et al. 2007;
Hirose et al. 2004). The PDZ domain of Tamalin was shown to interact with PSD-95, a critical
scaffolding protein that serves as the bedrock of the postsynaptic density and interacts also with
the NR2 subunit of NMDAR (Kitano et al. 2003). Tamalin also interacts with the PDZ domain
proteins MINT2 (C. elegans homolog: LIN-10) and CASK (C. elegans homolog: LIN-2), known
to directly bind and regulate nematode AMAPR expression (Chang and Rongo 2005; Rongo and
Kaplan 1999). Tamalin is auto-inhibited by its C-terminal tail as it binds to the PDZ motif to induce
a closed, inactive conformation. Binding of ligand (such as GluRs or a PDZ-domain protein) to its
N terminal PDZ domain induces an open and active conformation (Sugi et al. 2007). Therefore,
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data from mammalian studies of Tamalin/GRAS-1 mark it as a prime candidate to serve as a link
between GluRs and the Cytohesin/IIS cascade (Figure 8).
In summary, excitotoxicity is a key neurodegenerative mechanism responsible for much of
the damage in brain ischemia and a contributor to chronic neurological diseases. Recent studies
suggest

that

the large

complexes

density trigger both neurodegenerative

associated

with GluRs

processes and pro-survival

in

the

postsynaptic

cascades that

activate

concerted transcriptional programs of neuroprotection. A leading candidate contributor to the
specific activation of neuroprotective genes is the evolutionary-conserved Insulin/IGF Signaling
(IIS) cascade, which regulates the activity of the transcription factor FoxO/DAF-16. Using our C.
elegans model of excitotoxicity, we have recently shown that inhibition of the IIS pathway (which
results in increased FoxO/DAF-16 nuclear activity) reduces neurodegeneration. Furthermore, we
have shown that a protein complex containing Cytohesin/GRP-1 is an important upstream
regulator of IIS signaling in excitotoxicity. We are now considering the possibility that GluRs
communicate with the Cytohesin complex and the IIS pathway to modulate susceptibility to
excitotoxicity, possibly via the scaffolding protein Tamalin/GRAS-1. Investigation into the
role that Tamalin plays in excitotoxicity and neuroprotection will help us understand how
neuroprotection is regulated during excitotoxicity. We ask if Tamalin bridges communication
between GluRs and Cytohesin and regulate neuroprotection via the IIS pathway under
excitotoxicity, thus providing a second conduit to Glu signaling in neuroprotection (in addition to
the currently recognized role of CREB). Furthermore, we ask how the IIS cascade contributes to
the transcriptional regulation of specific genes, thereby providing neuroprotection in
excitotoxicity.

25

1.21

Hypothesis

Our overall hypothesis is that, during excitotoxicity, glutamate triggers a number of
signaling cascades that work in concert to produce a carefully-tailored stimulus-specific
transcriptional neuroprotective program. We specifically hypothesize that FoxO/DAF-16 is one of
the transcription factors that participates in increasing the neuroprotective signaling to combat the
neurodegenerative effects seen under excitotoxicity. Most importantly, we propose that
Tamalin/GRAS-1 is a functional link that allows communication between GluRs and the IIS
cascade, adjusting the level of activity of the IIS cascade, and regulating the balance of
neurodegeneration vs neuroprotection (Figure 9).
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2.1 Abstract
Glutamate is a major neurotransmitter that is involved in most synaptic functions. Regulation of
signaling by the neurotransmitter glutamate (Glu) is essential for neuronal physiology that include
learning, longevity, cell survival, metabolic functions, etc. Dysregulation of Glu culminates in
neuronal calamity. Excitotoxicity, a condition that arises from the accumulation of Glu in the
synapse that leads to the over activation of Glu receptors (GluRs), is a common mechanism of
neurodegeneration in brain ischemia and across many neurological diseases. Although it is
commonly acknowledged that over activation of GluRs leads to neurodegeneration, it has been
recently shown that even during excitotoxicity Glu also has a concurrent important role in
regulating neuroprotection. GluR-activated transcription factors seem to mediate this
neuroprotection, but it remains unclear which signaling cascades and transcription factors are
regulated by GluRs in excitotoxicity. The Insulin/IGF Signaling (IIS) cascade is intensely studied
for its role in regulating longevity and cell stress resistance. We have previously shown that the
IIS cascade also regulates neuroprotection in excitotoxicity in the nematode via its role in
regulating transcription factor DAF-16. However, a link between GluRs and the IIS cascade has
not been sufficiently investigated. We suggest that GluRs may regulate the IIS cascade via
complex formation at the postsynaptic density. Here we identify the scaffolding protein
Tamalin/GRAS-1 as a functional link mediating the communication between GluRs and IIS. We
found Tamalin/GRAS-1 to be important in regulating neuroprotection by working cell
autonomously via the IIS cascade. We also show that there is a physical link between GluRs and
upstream regulation of the IIS cascade whose activity is controlled by Tamalin/GRAS-1. These
studies suggest a novel conduit of communication between Glu and insulin signaling to regulate
susceptibility to excitotoxic neurodegeneration.

37

2.2 Introduction
2.2.1 Neuroprotective role of Insulin/IGF-1 signaling cascade under excitotoxicity
As discussed in the previous chapter, the Insulin/IGF-1 signaling cascade is a mediator of
neuroprotection in a nematode model of excitotoxicity. The activation of the IIS cascade leads to
the phosphorylation of transcription factor DAF-16. Once phosphorylated, DAF-16 is unable to
enter the nucleus. As shown by us together with the Kalb lab, the localization of DAF-16 in the
nucleus is sufficient for the neuroprotection mediated by IIS under excitotoxicity. Thus,
neuroprotection is mediated by the inhibition of the IIS cascade, which then allows for DAF-16 to
freely enter the nucleus and transcribe neuroprotective genes (Mojsilovic-Petrovic et al. 2009;
Tehrani et al. 2014).
2.2.2 The Cytohesin complex is an upstream regulator of the Insulin/IGF-1 Signaling
Cascade
The Cytohesin family consists of four known members: Cytohesin-1, Cytohesin-2,
Cytohesin-3/GRP-1, and Cytohesin-4. The binding domains of Cytohesin include amino-terminus
coiled-coil domain, Sec7-domain, and carboxy-terminal pleckstrin homology (PH). Cytohesin-3
had been identified as having strong interactions with phosphatidylinositol-3,4,5-triphosphate
(PIP3) and as an activator of Phosphatidylinositol-3-kinase (PI3K/AGE-1), through inositolphospholipid binding by the PH domains. The complex includes interactions between three
proteins: Cytohesin/GRP-1, ARF (adenosine diphosphate ribosylation factor) and PIP5K/PPK-1.
Adenosine diphosphate ribosylation factor (ARF) are myristoylated at their amino-termini and
require covalent lipid modification, as done by Cytohesin, for interactions with the membrane
(D’Souza-Schorey and Chavrier 2006; Kahn et al. 2006; Kahn et al. 2005; Nie and Randazzo
2006; Nie et al. 2003; Munro 2005; Donaldson and Honda 2005; Kolanus 2007). ARFs are able
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to interact with Cytohesin through the PH domain, which than permits Cytohesin access to the cell
membrane. ARF proteins are capable of activating phospholipase D, and lipid kinases such as
phosphatidyl 4-phosphate 5-kinase (PIP5K)(Kolanus 2007; Hafner et al. 2006).

Together,

Cytohesin, ARF and PIP5K allow for membrane localization and the production of substrate PIP3,
a necessary component of the IIS cascade.
2.2.3

Tamalin is a scaffolding protein with multiple binding domains

The post-synaptic density (PSD) of a neuron is an area of high concentration of scaffolding
proteins that link membrane receptors with enzymes and signaling proteins to facilitate activity
and connectivity right at the nano-domain closest to the synapse. The complex derives its name
from the fact that it can be visualized under electron microscopy as densely packed regions. The
95-kDa postsynaptic density protein (PSD-95) is a key scaffolding protein localized to excitatory
synapses and it plays a role in functional assembly of postsynaptic macromolecular complex (Kim
and Sheng 2004). Additional PDZ-domain scaffolding proteins are also found in the PSD, with
similar roles. PSD-95 uses its PDZ domains to interact with proteins that contain a PDZ binding
motif, allowing it to intermingle with both membrane bound (i. e. NMDA and AMPA receptors)
and cytoplasmic proteins (such as SynGAP and nNOS). PDZ domain-containing scaffolding
proteins are also important in subcellular trafficking of proteins associated with PSD-95 by
assembling cargo complexes for transport by molecular motors (Kim and Sheng 2004; Kitano et
al. 2003; Kim et al. 1997; Sheng and Sala 2001; Bredt 1998). Some known PDZ domaincontaining proteins in C. elegans include LIN-2, LIN-7 and LIN-10. These proteins are
mammalian homologs of scaffolding proteins important for diverse mechanisms underlying
neuronal activity and function (Rongo et al. 1998; Bredt 1998; Sheng and Sala 2001; Kitano et al.
2003; Glodowski et al. 2005; Feng and Zhang 2009) . MAGI is another multi-PDZ domain
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synaptic scaffolding protein that was shown to control GLR-1 clustering in some interneurons of
C. elegans during associative learning and memory (Stetak et al. 2009).
Tamalin/GRAS-1, GRP1-associated scaffold protein, is a scaffolding protein comprised of
multiple protein-interacting domains: a PDZ domain, a leucine-zipper domain, a proline rich
region, and a carboxyl termini PDZ binding motif (Kitano et al. 2002; Nevrivy et al. 2000; Ogawa
et al. 2007; Sugi et al. 2007)(Figure 10). Thus far, the known interactions of the PDZ domain of
Tamalin/GRAS-1 include the carboxyl termini
of group 1 and group 2 metabotropic glutamate
receptors

(mGluRs),

GABAB2

receptors

(Kitano et al. 2002; Kimura et al. 2004; Sugi et
al. 2007) and TrkC receptors (Esteban et al.
2006; Feng and Zhang 2009).
The leucine-zipper domain binds to the coiled coil region of guanine nucleotide exchange
factor Cytohesins (Kitano et al. 2002; Kitano et al. 2003; Nevrivy et al. 2000). The known
functions of Tamalin/GRAS-1 include intracellular trafficking and cell surface expression of group
1 mGluRs in COS-7 cells and cultured hippocampal neurons through interaction with Cytohesins
(Kitano et al. 2002; Hirose et al. 2004). Due to its multiple, distinct protein-interacting domains
and enrichment in the PSD region, Tamalin/GRAS-1 possibly has other complex interactions
under unique conditions such as excitotoxicity.
2.2.4

Tamalin interaction with the Cytohesin complex and GluRs

Thus far, it has been established that the IIS cascade regulates neuroprotection under
excitotoxicity and that the Cytohesin complex is an upstream regulator of the pathway. It is also
known that even under excitotoxicity, GluRs regulate delayed onset neuroprotection. However, it
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remains to be seen whether the IIS pathway is one such pathway regulated by GluRs to mediate
neuroprotection under excitotoxicity. The multiple domains of Tamalin/GRAS-1 make it an ideal
contender to be a bridge between GluRs and the Cytohesin-IIS pathway. Yeast-two hybrid
experiments showed interaction between Tamalin/GRAS-1 and GRP-1 (Cytohesin-3) (Nevrivy et
al. 2000). Another set of yeast-two hybrid experiment revealed Tamalin/GRAS-1 to interact with
mGluRs PDZ domain and the C-terminal half of Tamalin/GRAS-1 was bound to Cytohesin
(Kitano et al. 2002). Later studies found the Ala/Pro rich region of Tamalin/GRAS-1 to directly
interact with the SH3 region of Cytohesin and be a necessary component for ARF activation (Attar
and Santy 2013). Thus, Tamalin/GRAS-1 not only binds to Cytohesin but is necessary for ARF
activation, which is essential for stimulation of the IIS cascade. The phosphatidylinositol 4,5bisphosphate (PIP2) was found to have a PDZ domain recognition mode, as revealed by its crystal
structure of the phosphate-bound PDZ domain (Sugi et al. 2008). An interaction between the α2
helix in the Tamalin/GRAS-1 PDZ domain and two phosphates groups of PIP2 were observed
(Sugi et al. 2008). These studies together showcase multiple methods via which Tamalin/GRAS1 can interact or regulate the IIS pathway. Most importantly, the ability of Tamalin to sense binding
of a ligand to its PDZ domain, change confirmation (Sugi et al. 2007), and activate cytohesin
attests to its capacity to not only act as a scaffold protein (enticing other proteins to interact), but
also as an operative signaling molecule, endowed with the capability to control the activity of a
critical signaling cascade.
The results from this study hold promise that Tamalin/GRAS-1 may also have a direct or
indirect interaction with GLR-1. If true, the interaction between Tamalin/GRAS-1 may have with
GLR-1 and Cytohesin would lead to the establishment of an unexplored pathway via which GLR1 may regulate neuroprotection under excitotoxic conditions.
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2.3 Results:
2.3.1 Tamalin/GRAS-1 is widely expressed, including in neuronal processes
To characterize Tamalin/GRAS-1 expression we created animals transgenic for a construct
where expression of Tamalin/GRAS-1 fused to GFP was driven by 1000bp promoter, found
directly upstream of the start codon of Tamalin/GRAS-1. We observed that Tamalin/GRAS-1
expression is diffuse throughout the head region of the worm, including in the neurites of the
nerve ring and in the pharynx. We than crossed this strain with a strain where synaptically
localized GluRs are labeled in red, using GLR-1::RFP (Schaefer and Rongo 2006) to
confirm Tamalin/GRAS-1 expression includes the neurites of GLR-1 expressing neurons.
Fluorescent microscopy showed overlapping expression of synaptically-localized GLR-1::RFP
and Tamalin/GRAS-1::GFP (Figure 11 A). To confirm a physical interaction between the two
proteins we conducted co-Immuno-Precipitation (co-IP) from whole-worm membrane fraction
using anti-GFP to precipitate GRAS-1::GFP, and using anti-RFP to detect GLR-1::RFP. Co-IP
experiments in C. elegans are technically challenging in comparison to similar experiments
mammalian systems (due to challenges posed by the cuticle and the proteomic complexity of the
whole-animal sample) (Moresco et al. 2010). Nonetheless, our western blot analysis confirms
the presence of GLR-1::RFP in a Tamalin/GRAS-1::GFP IP sample prep (Fig 11 B). These
results show that in GLR-1 –expressing neurons Tamalin/GRAS-1 is found in a complex that
includes synaptic GluRs. We later found that membrane complexes that contain synaptic GluRs
also contain the Cytohesin complex resident protein PIP5K/PPK-1 (see below).
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These two analyses confirm that GRAS-1 is expressed in GLR-1 –expressing neurites and
is able to physically bind with GLR-1 (either directly or in a multi-protein membrane-associated
complex).
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2.3.2 Tamalin/GRAS-1 elimination reduces levels of excitotoxic neurodegeneration
We identified the role of Tamalin/GRAS-1 in excitotoxicity by observing the level of
neurodegeneration in a Tamalin/GRAS-1 KO excitotoxicity strain (gras-1;glt-3;nuIs5). We
measured neurodegeneration as vacuole-like structures in the head region of the worm, which
signified dying neurons. We counted dying neurons across the five developmental stages of the
worm and compared Tamalin/GRAS-1 KO (gras-1;glt-3;nuIs5) to WT (glt-3;nuIs5) and found
significant differences in neurodegeneration across the life stages (ANOVA: Interaction F(4,
760)=21, p<0.0001) (Fig 12). The neurodegeneration levels were found to be similar in larval
stage 1 and 2 across both strains (p=0.9). At larval stage 3 and 4 we observed a significant decrease
in neurodegeneration levels between gras-1;glt-3;nuIs5 and glt-3;nuIs5 (p<0.0001). At larval
stage 3 the neurodegeneration level for gras-1;glt-3;nuIs5 was found to average at 2 dying neurons
where as glt-3;nuIs5 showed neurodegeneration level averaged at 5 dying neurons. At larval stage
4, gras-1;glt-3;nuIs5 the neurodegeneration level was averaged at 2 dying neurons and glt3;nuIs5 the neurodegeneration level was found to be around 4. At the adult stage, gras-1;glt3;nuIs5 showed neurodegeneration level averaged at 1 dying neuron and glt-3;nuIs5 showed
neurodegeneration level averaged at 2 dying neurons. The differences at the adult stage between
the strains was not significantly different (p>0.1).

44

Figure 12:
Tamalin/GRAS-1 is an important regulator of neuroprotection in excitotoxic conditions. The
neurodegeneration level across the different life stages is shown. The neurodegeneration level
peaks at L3 stage for the glt-3;nuIs5 strain. ANOVA results show significant differences between
glt-3;nuIs5 and gras-1;glt-3;nuIs5 strains (F(4,760)=21,p<0.0001). Post-hoc Tukey analysis
show Tamalin/GRAS-1 mutation in excitotoxic conditions is sufficient to significantly reduce
neurodegeneration levels at L3 (p<0.0001) and L4 (p<0.0001) stages. n=60 **** p<0.0001
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2.3.3 Rescue of Tamalin/GRAS-1 in GLR-1 -expressing neurons shows Tamalin/GRAS-1 works
cell autonomously
To check whether Tamalin/GRAS-1 works cell autonomously in GLR-1 expressing neurons to
signal neurodegeneration in excitotoxicity, we performed a cell-type specific rescue of Tamalin.
To conduct this experiment, we constructed a plasmid expressing Tamalin/GRAS-1 fused to RFP
under GLR-1 promoter. We injected this plasmid in young adult gras-1;glt-3;nuIs5 worms with
co-injection marker MEC-4::GFP. We than screened for the co-injection marker to confirm the
worms with cell specific rescue of Tamalin. The strain created allowed us to look at the role of
Tamalin/GRAS-1 expression only in GLR-1 expressing neurons. We hypothesized that
Tamalin/GRAS-1 regulates neurodegeneration levels in GLR-1 expressing neurons. Thus,
Tamalin/GRAS-1 expression in GLR-1 expressing neurons would be sufficient to bring
neurodegeneration levels to Tamalin/GRAS-1 WT excitotoxicity level (glt-3;nuIs5). We counted
the neurodegeneration level in the Tamalin/GRAS-1 cell specific rescue strain (gras-1;glt3;nuIs5;Ex[Pglr-1GRAS-1::RFP;mec-4::GFP] and compared it to gras-1;glt-3;nuIs5 and glt3;nuIs5. The results for the rescue strain was expected to be similar to glt-3;nuIs5 strain if
Tamalin/GRAS-1 works cell autonomously in GLR-1 expressing neurons. Conversely, the results
was expected to be similar to gras-1;glt-3;nuIs5 if Tamalin/GRAS-1 does not work cell
autonomously. After quantifying the neurodegeneration level in the different life stages across the
different strains we found significant differences (ANOVA Interaction F(4,1190)=38.84,
p<0.0001)(Fig 13). At larval stage 1 we found the neurodegeneration level to be around 2-3 across
the different strain with no significant differences. Larval stage 2 showed significant
differences with Tamalin/GRAS-1 rescue in GLR-1 neurons (gras-1;glt-3;nuIs5 and gras-1;glt3;nuIs5;Ex[Pglr-1GRAS-1::RFP;mec-4::GFP]) (p<0.05).
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At

larval

stage

3,

we

found

neurodegeneration level in gras-1;glt-3;nuIs5;Ex[Pglr-1GRAS-1::RFP;mec-4::GFP] to be around
5, gras-1;glt-3;nuIs5 to be around 3 with significant differences (p<0.0001). At larval stage 3, we
found gras-1;glt-3;nuIs5;Ex[Pglr-1GRAS-1::RFP;mec-4::GFP] and gras-1;glt-3;nuIs5 to
be significantly different (p>0.0001). Cell specific rescue seems to partially reinstate
neurodegeneration, possibly due to the fact that the transgene in this strain is
extrachromosomal. Larval stage 4 showed significant differences between glt-3;nuIs5 and gras1;glt-3;nuIs5, gras-1;glt-3;nuIs5 and gras-1;glt-3;nuIs5;Ex[Pglr-1GRAS-1::RFP;mec4::GFP] (p<0.001). Adult stage showed no significant differences (p=0.4). These observations
support that it is sufficient to express Tamalin/GRAS-1 in GLR-1 –expressing neurons to restore
their normal degeneration levels, in line with a cell-autonomous effect.

Figure
13:
Rescue
of
Tamalin/GRAS-1 in GLR-1
neurons shows Tamalin/GRAS-1
works
cell
autonomously.
Extrachromosomal
transgenic
worms expressing full length
Tamalin/GRAS-1 were scored
for
neurodegeneration
and
compared to basal excitotoxic
strain and Tamalin/GRAS-1 KO
excitotoxic strain. ANOVA
Interaction analysis showed
significant
changes
in
neurodegeneration level between
the strains across the different
life stages (F(4,1190)=38.84,
p<0.0001). Post-hoc Tukey analysis show significant increases in neurodegeneration levels at L3
(p<0.0001) and L4 (p<0.001) stages for rescue of Tamalin/GRAS-1 in GLR-1 expressing neurons.
Tamalin/GRAS-1 overexpression in GLR-1 neurons showed significant difference to basal
excitotoxic strain (F(4,1129)=3.382, p=0.009). Tamalin/GRAS-1 overexpression showed
significant decrease in neurodegeneration compared to basal excitotoxic strain at L3 (p=0.0002)
and adult stage (p=0.04). n=120 * p<0.05, *** p<0.001, **** p<0.0001
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2.3.4 Overexpression of Tamalin/GRAS-1 in GLR-1 neurons does not seem to exacerbate
Neurodegeneration
To evaluate how overexpression of Tamalin/GRAS-1 affects neurodegeneration, Tamalin/GRAS1 was overexpressed under the GLR-1 promoter in the glt-3nuIs5 strain. The neurodegeneration
levels of the transgenic worms were quantified at all life stages of the worm and compared to that
of the excitotoxic control (glt-3;nuIs5) and Tamalin/GRAS-1 KO (gras-1;glt-3;nuIs5). Statistical
analysis showed overall significant differences in neurodegeneration levels across the life stages
(ANOVA

Interaction F(4,1129)=3.382,

p=0.009)(Fig

13). Post-hoc

analysis

showed

neurodegeneration levels of glt-3;nuIs5;Ex[Pglr-1::GRAS-1::RFP;mec-4::GFP] to be slightly but
significantly lower than glt-3;nuIs5 at L3 (p=0.0002) and adult stage (p=0.04). Thus, it was
concluded that overexpression of Tamalin/GRAS-1 does not exacerbate the neurodegenerative
effects, and might have a minor effect in reducing neurodegeneration, possibly by overwhelming
the interactions of endogenous Tamalin/GRAS-1.
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2.3.5 Tamalin/GRAS-1 KO protects motor neurons more so than other category of neurons
Tamalin/GRAS-1 expression in the nerve ring seems rather uniform (Fig 11), and similar
expression was previously reported for the Insulin Receptor/DAF-2 (Kimura et al. 2011).
However, we have recently found that the extent of excitotoxic neurodegeneration is not uniform
throughout the 30 neurons subjected to the excitotoxic insult in our model (Feldmann et al.
2019). In that study, we found that when the GLR-1–expressing neurons are exposed to the
excitotoxic insult (in otherwise WT background) the command interneurons, which express the
highest levels of GluRs (Brockie et al. 2001a), died less frequently than the GLR-1 –
expressing motorneurons. We also saw that CREB has a more pronounced neuroprotective effect
in those command interneurons. Therefore, we next looked across GLR-1 neurons for differential
Tamalin/GRAS-1 sensitivity.
After collecting images from both strains, we than analyzed dying neurons using the GFP
marker expressed in the GLR-1 neurons. We first located the swollen cells, then superimposed
the GFP image on the DIC image. We then used the position and orientation of the processes of
the GFP cell to identify which GLR-1 expressing neuron was dying. Using this technique, 30
worms per strain were evaluated. Initially, when examining the individual susceptibility of
each identified neuron to degeneration in the presence or absence of Tamalin/GRAS-1, the
effects that we saw were too variable to be statistically significant (ANOVA Interaction F(15,
1008)=1.491, p=0.1) (Fig 14). However when we grouped the identified neurons together by
category (Sensory, Motor or Interneurons, based on WormAtlas, as done in our previous study
(Feldmann et al. 2019)) we found that in these neuronal groups the differences between
neurodegeneration levels in the presence vs absence of Tamalin/GRAS1 is statistically significant (ANOVA Interaction F(3,252)=2.719, p=0.04). Post-hoc analysis

49

revealed significant differences in neurodegeneration of Sensory (p=0.02) and Motor (p=0.008)
neurons between the strains.

Figure 14:
Dying neurons under excitotoxicity
were identified and their frequency of
death was quantified. Tamalin/GRAS1 KO seems to protect motor neurons
more so than other category of
neurons. The nerve ring in the head
region of the worm were imaged for
basal excitotoxic condition and
Tamalin/GRAS-1 KO excitotoxic
condition, with oil as an immobilizer.
Thirty worms per strain were than
used to identify and quantify dying neurons in the head region. An ANOVA Interaction analysis
showed significant differences between the categories of neurons dying between the strains (F(3,
252)=2.719, p<0.04). Post-hoc Sidak (used because means of each category were being
compared to each other) analysis showed Tamalin/GRAS-1 KO significantly reduced
neurodegeneration levels of Sensory (p<0.02) and Motor (p<0.008) neurons.
n=30 * p<0.05, ** p<0.01
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Thus, these results show that Tamalin/GRAS-1 has a preferential role in balancing
neuroprotection and neurodegeneration in the glr-1 –expressing motor neurons (which include
the SMDs and RMDs).
2.3.6 Tamalin/GRAS-1 works via the IIS pathway to reduce neurodegeneration
After finding Tamalin/GRAS-1 is able to regulate neurodegeneration level in excitotoxicity we
wanted to investigate whether Tamalin/GRAS-1 works via the IIS pathway to carry out this affect.
We examined epistasis between Tamalin/GRAS-1 and the IIS cascade by created a gras-1;age1;glt-3;nuIs5 strain and comparing it to gras-1;glt-3;nuIs5, age-1;glt-3;nuIs5 and glt-3;nuIs5. We
measured the level of neurodegeneration in these strains across different developmental stages and
found significant differences in neurodegeneration across the different life stages (ANOVA
Interaction F(12, 780) =14.82, p<0.0001)(Fig 15). We did not find significant differences at larval
stages 1 and 2 with neurodegeneration levels around 1 and 2, respectively (p>0.3 to 0.9). At larval
stage 3, we found significant differences between glt-3;nuIs5 and the other strains (p<0.0001).
The neurodegeneration level at larval stage 3 for glt-3;nuIs5 was around 6. The neurodegeneration
level for gras-1;age-1;glt-3;nuIs5, gras-1;glt-3;nuIs5 and age-1;glt-3;nuIs5 at larval stage 3 was
around 3. At larval stage 4, glt-3;nuIs5 was significantly different from all other strain (p<0.0001),
with neurodegeneration differences of 5 to 2. At adult stage, all strains had neurodegeneration level
averaging around 1 with no significant differences. Therefore, adding either age-1 or gras-1
mutations to the excitotoxicity strain (glt-3;nuIs5) reduces neurodegeneration, but the effect of
age-1 and gras-1 is similar, and combining both of them has no additional effect on
neurodegeneration. These results suggest that Tamalin/GRAS-1 does in fact work in the same
pathway as IIS pathway to regulate neurodegeneration levels since we see neurodegeneration
levels to be the similar when both Tamalin/GRAS-1 and AGE-1 are mutated. If these were in fact
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separate pathways, we would expect to see an additive affect in the neurodegeneration when both
are mutated.

Figure 15: Tamalin/GRAS-1 works via the Insulin/IGF-1 Signaling cascade to regulate
neurodegeneration levels under excitotoxic conditions. Tamalin/GRAS-1 and AGE-1 KO
significantly reduce neurodegeneration compared to basal excitotoxic conditions
(F(12,436)=10.35, p<0.0001). Post hoc Tukey analysis across the different life stages of the
worm show Tamalin/GRAS-1 and AGE-1 KO significantly reduce neurodegeneration levels at
L2, L3 and L4 stages (p<0.005 to p<0.0001). Mutation of both Tamalin/GRAS-1 and AGE-1
under excitotoxic conditions resulted in neurodegeneration levels similar to Tamalin/GRAS-1
and AGE-1 alone. n=5-30 ** p<0.01*** p<0.001**** p<0.0001
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2.3.7 Tamalin/age-1 KO regulates neurodegeneration independent of upstream GLR-1 regulation
As described in previous sections, mammalian Cytohesin and the IIS cascade have been proposed
to modify the expression levels of GluRs. Therefore, a trivial reason for the reduced excitotoxicity
in IIS –modifying mutations could have been that fewer GluRs are functionally expressed in these
mutants, reducing the magnitude of the excitotoxic insult. We therefore wanted to design an
experiment that would evaluate whether Tamalin/GRAS-1 or AGE-1 mutation regulate the overall
activity level of GluRs (and might therefore exert neuroprotection by downsregulateing Glu
signaling). Thus, we conducted classical behavioral experiments that would test the sensitivity and
activity of GLR-1 in the Tamalin/GRAS-1 KO and AGE-1 mutant strains. We hypothesized that
GLR-1 activity is not affected by Tamalin/GRAS-1 KO or AGE-1 mutant and the reduction in
neurodegeneration we see is due to a downstream regulation of transcription factors not an
upstream regulation of GLR-1. To test this, we performed the nose touch assay and the
spontaneous forward mobility assay, because these assays have been well documented to be
sensitive to even small changes in the expression or trafficking of GluRs. We performed these
assays on synchronized larval stage 4 worms. Well-fed L4 worms were washed and placed on
large plates without food. Worms were left to acclimate for 30 minutes. We first performed the
spontaneous forward mobility assay by just observing and recording the forward mobility of the
worms. We then performed the nose touch assay by placing a hair pick in the path of a moving
worm and recording the percentage of backward response. We repeated the nose touch assay 5
times per worm and averaged the response as a fraction (?/5). We performed these two assays in
N2 (positive control), nmr-1;glr-1glr-2 (negative control), gras-1 and age-1 (experimental)
strains. For the nose touch assay the N2 strain had an 86% backward response rate to the stimulus.
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The nmr-1;glr-1glr-2 strain had a 25% backward response rate. The gras-1 and age-1 strains both
had 80% backward response rate.
Figure 16:
Tamalin/GRAS-1
and AGE-1 KO does
not affect upstream
regulation of GluRs.
Forward mobility
assay (A) and nose
touch analysis (B)
were conducted to
test the sensitivity
and function of
GLR-1 in Tamalin/GRAS-1 and AGE-1 mutants. Results were compared to N2 (positive control)
and nmr-1;glr1 glr2 (negative control). ANOVA Between analysis for the mobility assay
showed overall significance (F(3,391)=29.04, p<0.001). Post-hoc Sidak analysis shows all
strains to be significantly different from the negative control strain (p<0.001). ANOVA Between
analysis for the Nose touch assay showed overall significant differences (F(3,390)=135.6,
p<0.001). Post-hoc Sidak (used because means of each group were being compared to each
other) analysis showed all strains to be significantly different from the negative control strain
(p<0.001). n=90

Statistical

analysis showed

overall

significance

between

the

groups

(ANOVA

between F(3,390)=135.6, p<0.001)(Fig 16). Post hoc analysis showed all strains to be
significantly different from nmr-1;glr-1glr-2 (p<0.001). For the spontaneous forward mobility
assay the N2 strain had an average forward mobility duration of about 26 secs. The nmr-1;glr1glr-2 strain had an average forward mobility duration of about 115 secs. Both gras-1 and age1 had an average forward mobility duration of about 30-40 secs. Statistical analysis showed overall
significance between the groups (ANOVA between F(3,391)=29.04, p<0.001)(Fig 16). Post hoc
analysis showed all strains to be significantly different from nmr-1;glr-1glr-2 (p<0.001). Both
behavioral assays together show that both gras-1 and age-1 strains had results similar to the N2
(positive) strain, suggesting that GluRs’ sensitivity and activity is in not compromised in these
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strains. These observations support that the reduced neurodegeneration conferred by these
mutations is not due to a reduced intensity of GluR-mediated insult and is likely to stem from
reduced neurodegenerative effect downstream of GluR activity.
2.3.8 DAF-16 localization dependent on Tamalin/GRAS-1
The previous results demonstrated that Tamalin/GRAS-1 does not reduce excitotoxicity
postsynaptically by upstream regulation of GluRs. We thus suspected that the reduction in
neurodegeneration we found might be from downstream regulation of DAF-16 to increase
neuroprotection under excitotoxicity. We next investigated the effect of Tamalin/GRAS-1 KO on
DAF-16 localization. To conduct this experiment, we took a DAF-16a (the DAF-16 isoform that
is enriched in neurons) fused to RFP to visualize its subcellular localization and crossed it with our
Tamalin/GRAS-1 KO strain (gras-1). We than imaged the new strain for RFP and compared the
results with DAF-16a::RFP. The results show that Tamalin/GRAS-1 KO is sufficient for DAF-16
nuclear localization (Fig 17).

Figure 17:
DAF-16 localizes to the nucleus under excitotoxic conditions and Tamalin/GRAS-1 KO. DAF16 in WT conditions is diffuse throughout the cell and more localized in the cytosol of some
cells. Tamalin/GRAS-1 mutation leads to localization of DAF-16 in most cells in the head region
of the worm. Images not quantified.
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2.3.9 Triggering excitotoxicity causes translocation of FoxO/DAF-16 to the nucleus
Earlier in this study we observed a critical correlation, where Tamalin/GRAS-1 elimination is
neuroprotective (Fig 12-15) while it also increases FoxO/DAF-16’s nuclear localization in a WT
background (Fig 18), two functions associated with a decrease in IIS signaling. We were
therefore interested to determine the effect of excitotoxicity on FoxO/DAF-16 nuclear
localization, as readout of the effect of GluR hyperactivation on the level of IIS activity. Using
the DAF-16a::RFP marker in the excitotoxicity strain (where GLR-1 -expressing neurons
subjected to the excitotoxic insult are labeled with GFP), we observe that FoxO/DAF-16
becomes specifically localized to the nucleus of some surviving GLR-1–expressing neurons
(Figure 18C-E). Quantification of the results show interneurons to be significantly more likely to
have DAF-16 localized to the nucleus of surviving GLR-1-expressing neurons (F(3,60)=17.35,
p<0.01)(p<0.001). This effect is seen only in the GLR-1–expressing neurons targeted by our
excitotoxicity model. Therefore, these observations suggest that excitotoxic conditions cellautonomously trigger FoxO/DAF-16 translocation to the nucleus. Together with our previous
observations on Tamalin/GRAS-1, these observations suggest the nematode excitotoxicity and
Tamalin/GRAS-1 –mediated interactions regulate the activity of the IIS cascade to
control susceptibility to neurodegeneration.
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Figure 18: DAF-16 localizes to the nucleus under excitotoxicity.
Frequency of live neurons with DAF016 localized to the nucleus
were quantified. Level of DAF-16 localized to the nucleus was
not measured. (A) Quantification of GLR-1 neurons dying under
excitotoxicity. (B) Data from (A) grouped by category
(F(3,60)=20.75,p<0.01; Posthoc Tukey p<0.001) (C)
Quantification of GLR-1 neurons with DAF-16 localized to the
nucleus (D) Data from (C) grouped by category
(F(3,60)=17.35,p<0.01;Posthoc Tukey p<0.001) (E) A merged
image of DAF-16 (RFP) and GLR-1 expressing neurons (GFP)
show DAF-16 localized in the nucleus in some GLR-1
expressing neurons (square). Dying GLR-1 neurons do not show
DAF-16 localized to the nucleus (circle).
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2.3.10 Leucine Zipper domain overexpression shows slight effect in lowering
Neurodegeneration
In order to further examine the role of Tamalin/GRAS-1 and its interaction with GLR-1 and the
IIS cascade, we evaluated the effects of overexpression of the domains of Tamalin. The goal of
this experiment was to isolate the interactions of Tamalin/GRAS-1 and observe if disrupting the
interactions of Tamalin/GRAS-1 was sufficient to disrupt the neurodegenerative effects of
Tamalin. Overexpression and rescue of the Leucine Zipper domain was performed to evaluate
the effect of separating the interaction of the IIS cascade and GLR-1 receptor. For this
experiment, Leucine Zipper domain under the GLR-1 promoter was injected into glt3;nuIs5 and gras-1;glt-3;nuIs5 to evaluate the overexpression and rescue of the Tamalin/GRAS1 Leucine Zipper domain. After confirming the strains, the neurodegeneration levels were
quantified and overall significant differences were found (ANOVA
Interaction F(12,1280)=30.46, p<0.0001)(Fig 19). The data showed that overexpression of the
Leucine Zipper domain in glt-3;nuIs5 significantly reduced neurodegeneration levels in L2, L4
and adult stage (p<0.001). Together the data suggest while the rescue of the Leucine Zipper
domain does not have an effect in the absence of endogenous Tamalin, the over expression of
Leucine Zipper domain in the presence of endogenous Tamalin/GRAS-1 (glt-3;nuIs5; Ex[Pglr1::GRAS-1_LeuZip::RFP;MEC-4::GFP]) seems to moderately reduce neurodegeneration
compared to the control (glt-3;nuIs5). This result suggests that the Leucine Zipper domain might
block interaction of endogenous Tamalin/GRAS-1 with Cytohesin and the IIS cascade.
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Figure 19:
Tamalin/GRAS-1 Leucine Zipper domain overexpression
shows slight effect in lowering neurodegeneration compared
to basal excitotoxic conditions. Replacing the
Tamalin/GRAS-1 Leucine Zipper domain in Tamalin/GRAS1 KO excitotoxic conditions does not make much changes in
neurodegeneration levels. An ANOVA Interaction analysis
show overall significant differences in neurodegeneration
levels between the strains across the different life stages of
the worm (F(12,1280)=30.46, p<0.0001). Post-hoc Tukey
analysis shows overexpression of the Tamalin/GRAS-1
Leucine Zipper domain under basal excitotoxic conditions significantly reduced
neurodegeneration levels at L2, L4 and adult stages compared to basal excitotoxic conditions
(p<0.001). Replacing Tamalin/GRAS-1 Leucine Zipper domain in Tamalin/GRAS-1 KO
excitotoxic conditions significantly increased neurodegeneration level compared
Tamalin/GRAS-1 excitotoxic conditions (p<0.01). Image of localization of Tamalin Leucine
Zipper under GLR-1 promoter also shown. n=65 ** p<0.01, *** p<0.001, **** p<0.0001
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2.3.11 Overexpression of PDZ domain sufficient to reinstate neurodegeneration comparable to
full length Tamalin/GRAS-1
The PDZ domain of Tamalin/GRAS-1 allows the interaction between Tamalin/GRAS-1 and GLR1 and other postsynaptic density proteins. For this experiment, plasmids for PDZ expression fused
to RFP was placed under GLR-1 promoter. The plasmids were injected into glt-3;nuIs5 and gras1;glt-3;nuIs5 backgrounds to examine the effects of overexpression and rescue of the
Tamalin/GRAS-1 PDZ domains. After confirming the strains neurodegeneration data were
collected by counting vacuole-like structures in the head region of the worm at all life
stages. Statistical analysis showed overall significant differences in neurodegeneration across
some of the different life stages between the strains (ANOVA Interaction F(12,444)=7.316,
p<0.0001) (Fig 20). As the graph here shows, overexpression of the PDZ domain in the presence
of endogenous Tamalin/GRAS-1 (glt-3;nuIs5;Ex[Pglr-1::GRAS-1_PDZ::RFP;MEC-4::GFP])
did not have an effect on neurodegeneration as compared to its control (glt-3;nuIs5) (ANOVA
Interaction F(4,209)=2.003, p=0.09). However, rescue of only the PDZ domain expression in the
absence

of

endogenous

Tamalin/GRAS-1

(gras-1;glt-3;nuIs5;

Ex[Pglr-1::GRAS-

1_PDZ::RFP;MEC-4::GFP]) reinstated neurodegeneration levels to that of rescue observed in the
presence of full length Tamalin/GRAS-1 (glt-3;nuIs5) (ANOVA Interaction F(4,235)=20.98,
p<0.0001). Post hoc analysis show significant differences between gras-1;glt-3;nuIs5 and gras1;glt-3;nuIs5;

Ex[Pglr-1::GRAS-1_PDZ::RFP;MEC-4::GFP] in

L2

to

Adult

life

stages (p<0.001). These results suggest that it is sufficient to express only the PDZ domain of
Tamalin/GRAS-1 in GLR-1-expressing neurons to express its full potential to increase excitotoxic
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neurodegeneration, even in the absence of Tamalin-Cytohesin connection (as no Tamalin/GRAS1 Leucine Zipper is expressed in these animals).

Figure 20: Overexpression of Tamalin/GRAS-1 PDZ domain in
Tamalin/GRAS-1 KO excitotoxic conditions is sufficient in
reinstating neurodegeneration comparable to full length
Tamalin/GRAS-1. Overexpression of Tamalin/GRAS-1 PDZ domain
in basal excitotoxic conditions does not change neurodegeneration
levels. An ANOVA of Interaction analysis show overall significance
between the strains across the different life stages of the worm
(F(12,444)=7.316,
p<0.0001).
Overexpression
of
the
Tamalin/GRAS-1 PDZ domain in the presence of endogenous
Tamalin/GRAS-1 did not affect neurodegeneration compared to basal excitotoxic conditions
(F(4,209)=2.003, p=0.09). Overexpression of Tamalin/GRAS-1 PDZ domain in the absence of
endogenous Tamalin/GRAS-1 was sufficient to reinstate neurodegeneration levels to that of rescue
of full length Tamalin/GRAS-1 (ANOVA Interaction F(4,235)=20.98, p<0.0001). Post-hoc
Tukey analysis show Tamalin/GRAS-1 PDZ domain in the absence of endogenous
Tamalin/GRAS-1 significantly increased neurodegeneration levels compared to Tamalin/GRAS1 excitotoxic conditions in L2, L3, L4 and adult life stages (p<0.001). Image of localization of
Tamalin Leucine Zipper under GLR-1 promoter also shown. n=65 ** p<0.01, *** p<0.001, ****
p<0.0001
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2.3.12 GLR-1 and Tamalin/GRAS-1 interaction is independent of GLR-1 excitotoxicity
The compilation of the experiments suggests that the absence of Tamalin/GRAS-1 is
neuroprotective under basal excitotoxic conditions by the removal of DAF-16 inhibition. Our
results also show that DAF-16 localizes to the nucleus of some GLR-1 expressing neurons under
excitotoxic conditions. Thus, even under excitotoxic conditions neuroprotection is still mediated
by transcription factor DAF-16. In order to understand how the interaction of GLR-1 and
Tamalin/GRAS-1 facilitates neuroprotection under basal excitotoxic conditions we observed the
physical interaction between the two proteins. Our previous immunoprecipitation experiments
showed that GLR-1 and Tamalin/GRAS-1 physically binding under basal (non-excitotoxicity-)
conditions. We than checked if this physical bind remains under excitotoxicity (glr-1::RFP;glt3;nuIs5; Ex[Pglr-1::GRAS-1::GFP;MEC-4::RFP]). Again, we used anti-GFP to precipitate
GRAS-1::GFP, and used anti-RFP to detect GLR-1::RFP. Results here show that the physical
interaction between Tamalin/GRAS-1 and GLR-1 is not disrupted in excitotoxic conditions, as we
expected. However, though GluRs and Tamalin/GRAS-1 remain physically associated in the PSD
under both basal and excitotoxic conditions, it is still possible that the physiological interactions
between Tamalin/GRAS-1 and GLR-1 change between basal and excitotoxic conditions.

IR/IGF-1R/DAF-2
GluR

Glu

Glu

PIP5K/

ARF PPK-1
Tamalin/
PIP2
GRAS-1 Cytohesin/
PIP2

GRP-1
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PIP2

PIP2

Figure 21:
Immuno-precipitation
of Tamalin/GRAS-1
from the membrane
fraction shows bound
GLR-1. Pull down of
Tamalin/GRAS-1 in
basal and excitotoxic
conditions does not
show differences in
level of GLR-1 bound.

2.4 Conclusion and Discussion:
In this study we identified an important scaffolding protein, Tamalin/GRAS-1 that regulates
necrotic neurodegeneration in nematode excitotoxicity, functionally linking the effect of GluRs
and the Insulin/IGF signaling (IIS) cascade. We found that nematode Tamalin/GRAS-1 is
expressed in GLR-1 -expressing neurons and is physically bound or complexed with GLR-1 in
basal (non-excitotoxicity) conditions (Fig 11). We also found Tamalin/GRAS-1 to be an important
regulator of neuroprotection (Fig 12) and to work cell-autonomously, as Tamalin/GRAS-1
expression in just the GLR-1 expressing neurons is sufficient to reinstate the neurodegenerative
effects of excitotoxicity (Fig 13). We found overexpression of Tamalin/GRAS-1 did not
exacerbate the neurodegenerative effects (Fig 13).
Complementing our previous study on the effect of CREB/CRH-1 in nematode
excitotoxicity (Feldmann et al. 2019), we find that motor neurons are more susceptible than
interneurons to neurodegeneration under basal excitotoxic conditions, while the decrease in
neurodegeneration we see following Tamalin/GRAS-1 elimination comes to a large degree from
a decrease in motor neurons degeneration (Fig 14).
Studying the mechanism of Tamalin/GRAS-1’s effect on excitotoxicity we first verified
that it is not simply mediated by an upstream effect, changing the extent of the excitotoxic insult
by reducing the overall activity levels of glutamatergic circuits (Fig 16). Having previously shown
the importance of the IIS cascade in excitotoxicity (Tehrani et al. 2014), we now looked to see if
the effects of Tamalin/GRAS-1 is mediated via the IIS cascade. Epistasis analysis confirmed that
Tamalin/GRAS-1 works via the IIS cascade to regulate neuroprotection in excitotoxicity (Fig 15
left panel) and translocate FoxO/DAF-16 to the nucleus (Fig 17 right panel).
We therefore turned to investigate the possibility that Tamalin/GRAS-1 might physically
and functionally link GLR-1 to the IIS cascade. Though GLR-1, Tamalin/GRAS-1, and
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PIP3K/PPK-1 can be found associated (directly or indirectly) in the same membranal complex in
vivo, our data showed that eliminating Tamalin/GRAS-1 alone is not sufficient to break
apart GLR-1 from a component the Cytohesin complex (Fig S1), the upstream regulator of the IIS
cascade. It is possible that the association seen between GLR-1, Tamalin/GRAS-1, and the
Cytohesin complex (with its resident PIP5K/PPK-1) is a multi-valent effect through a multicomponent complex, so that in the absence of one scaffold protein, other scaffold proteins are
present holding the complex together (similarly to the large complexes formed in the mammalian
Post Synaptic Density (Kennedy 2000; Sheng and Kim 2002; Sheng and Kim 2011; Zeng et al.
2018)).
To understand the functional interaction between endogenously expressed Tamalin/GRAS1 and GLR-1 more clearly, we investigated how overexpression of the different domains of
Tamalin/GRAS-1 would affect the physiological effects we quantify. We found overexpression of
the

Leucine

Zipper

domain

of

Tamalin/GRAS-1

was moderately neuroprotective

in

excitotoxic conditions (Fig 19), in line with a model where a modestly expressed free Leucine
Zipper domain competes with endogenous Tamalin/GRAS-1 interaction with the IIS cascade. The
effect of overexpression of the PDZ domain of Tamalin/GRAS-1 was surprising: While it did not
produce a Tamalin/GRAS-1 elimination-like effect (which would be expected of an effect to
compete away the GluR-Tamalin/GRAS-1 interaction), it was sufficient to restore the
neurodegenerative effect of full-length Tamalin/GRAS-1 in Tamalin/GRAS-1 mutant excitotoxic
conditions (Fig 20). This leads us to conclude that the PDZ –based interactions between
Tamalin/GRAS-1 and GluRs or the PSD complex is versatile, complex, and might include
additional mediators that could also be affected by the overexpression of Tamalin/GRAS-1’s PDZ
domain and affect the IIS cascade. We tested the effect of one such candidate, Mint/X11/LIN-10
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(Rongo et al. 1998; Kitano et al. 2003; Chang and Rongo 2005; Rogelj et al. 2006; Borg et al.
1999) but could not determine an excitotoxicity-specific effect (Supp Fig S3). Among the
additional possible candidate PDZ-binding partners that could regulate the IIS cascade are APPL1
(Wang et al. 2012) and PTEN/DAF-18 (Jurado et al. 2010; Knafo et al. 2016; Shabanzadeh et al.
2019). Therefore, it seems that overexpression of the Tamalin/GRAS-1’s PDZ domain may modify
interactions of GluR signaling and the IIS cascade through additional, yet undetermined- pathways
to modify the neurodegenerative affects.
Critically, we find that that the excitotoxicity condition by itself modifies FoxO/DAF-16
nuclear localization in the neurons exposed to the excitotoxic insult (Fig 18). We therefore
conclude that the functional interaction between GLR-1 and Tamalin/GRAS-1 is a dynamic
element of determining suitability to neurodegeneration, an effect that is dependent on basal vs
excitotoxic conditions. We find that Tamalin/GRAS-1 and GLR-1 are found physically associated,
contained in a complex under basal conditions (as evident from co-IP results), while at this state
FoxO/DAF-16 is found diffused in the cytoplasm (fig 17). In contrast, both Tamalin/GRAS-1
elimination and excitotoxicity conditions cause FoxO/DAF-16 to accumulate in the nucleus. These
observations suggest that Tamalin/GRAS-1 enhances the activity of the IIS cascade and reduces
nuclear localization (and presumably phosphorylation) of FoxO/DAF-16. Therefore, we propose
a model where under excitotoxic conditions activated GluRs inhibit Tamalin/GRAS-1 and reduce
activity of the IIS cascade, to increase FoxO/DAF-16 localization to the nuclease and increase
neuroprotection. While PDZ-mediated interactions might include additional (yet unknown)
proteins, our study places Tamalin/GRAS-1 at the center of a novel conduit for glutamatergic
signaling to affect the IIS cascade and provide neuroprotection in the midst of the detrimental
effect of excitotoxicity on cell survival and demise.
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2.5 Materials & Methods:
C. elegans strains and crosses:
We received the mutant strain gras-1(tm2699) I from the Japanese National Bioresource Project
(NBRP, Ministry of Education, Culture, Science, Sports and Technology, Japan). We received
the age-1(hx546) II mutant strain and DAF16a::RFP from the Caenorhabditis Genetic Center
(CGC) at the Univ. of Minnesota. To label GLR-1 expression we used odIs16(Is[glr-1::rfp]) from
the Rongo lab (Schaefer and Rongo 2006). ppk-1 Over Expression: EG3361 (lin-15(n765ts) X,
gqIs25 [Prab-3::ppk-1, lin-15(+)] I (Garriga lab). Other previously used strains in our lab: WT:
Bristol N2 (RRID:CGC_N2 (ancestral)) ; Excitotoxicity strain: ZB1102: glt‐3(bz34) IV; nuIs5
[Pglr-1::gfp-1;Pglr-1::Gαs(Q227L)V(RRID:CGC_ZB1102) (Mano and Driscoll 2009). Negative
control for glutamatergic circuit strength: VM1268: nmr‐1(ak4) II; glr‐2(ak10) glr‐1(ky176) III
(Mellem et al. 2002). Strains made for this project: IMN50: gras-1(tm2699) I;glt-3 (bz34)
IV;nuIs5 V, IMN37: age-1(hx546) II;glt-3(bz34) IV;nuIs5 V, IMN51: gras-1(tm2699) I;age1(hx546) II;glt-3(bz34) IV;nuIs5 V, IMN52 (Tamalin/GRAS-1 rescue specifically in glr-1 –
expressing neurons): gras-1(tm2699) I;glt-3 (bz34) IV;nuIs5 V;Ex[Pglr-1GRAS-1::RFP ; MEC4::GFP], IMN53 (Tamalin/GRAS-1 overexpression): glt-3 (bz34) IV;nuIs5 V;Ex[Pglr-1::GRAS1::RFP ; MEC-4::GFP], IMN54 (GluRs & Cytohesin complex association): PPK-1::GFP;GLR1::RFP;gras-1, IMN55 (FoxO/DAF-16 localization in gras-1 ko):

DAF-16a::RFP;gras-

1(tm2699) I, IMN56 (FoxO/DAF-16 in sensitized background) DAF-16a::RFP;nuIs5 V, IMN57
(FoxO/DAF-16 localization in excitotoxicity): DAF-16a::RFP;glt-3(bz34) IV;nuIs5 V, IMN58
(FoxO/DAF-16 localization in excitotoxicity in gras-1 ko): DAF-16a::RFP; gras-1(tm2699)I;glt3 (bz34) IV;nuIs5 V.
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All the major new strains were constructed twice from independent crosses, and data was verified
to be similar. Strains were maintained at 20°C according to Brenner (Brenner 1974), and grown
on MYOB agar plates (Church et al. 1995) seeded with OP50 (Stiernagle 2006).

Plasmid Construction and transgenic animals:
Plasmids were constructed using genomic DNA extracted via PCR and inserted into target
plasmids based on the Fire lab vector pPD95.75. For Tamalin/GRAS-1 promoter we amplified
1000bp of the gras-1 upstream regulatory sequence (between nucleotides agtttctgctttt and
cgGGATCCCCG of cosmid F30F8; another ORF in the opposite direction is found merely ~400
bp upstream of the gras-1 ORF). For expression in GLR-1 –expressing neurons we used the glr-1
promoter from KP#889 (Pglr‐1::dsRed, a gift from the Kaplan and the Juo labs) (Kowalski et al.
2011)). PCR primers were designed to target regions of interests with restriction sites added at the
ends of the primers. Thus, the regions amplified could be cut to give sticky ends matching that on
the plasmid for ligations. Using this method the following plasmids were constructed: Pgras1::GRAS-1::GFP

(containing GRAS-1 genomic ORF, nucleotides 7970-9856 of cosmid F30F8),

Pglr-1::GRAS-1::RFP (containing GRAS-1 genomic ORF, nucleotides 8969-9856 of cosmid
F30F8), Pglr-1::PDZdomain::RFP (containing GRAS-1 genomic PDZ-encoding region,
nucleotides 8957-9511 of cosmid F30F8), Pglr-1::PDZdomain (containing GRAS-1 genomic PDZencoding region, nucleotides 8957-9511 of cosmid F30F8 without fusion to the RFP protein), Pglr1::LeucineZipper::RFP

(containing GRAS-1 genomic Leucine Zipper-encoding region,

nucleotides #8957-8973 and 9511-9612 of cosmid F30F8).
For microinjections and transgenic selection, day 1 adults were microinjected with a cocktail of
desired plasmid with co-injection marker of MEC-4::GFP/MEC-4::RFP (which is not expressed
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in head neurons). Injected hermaphrodites were placed on fresh plates. Offspring's were screened
for the co-injection marker and transgenic animals (F3 or later) were used for analysis.

Quantification of Neurodegeneration:
Neurodegeneration was counted in the head and tail of the worm as previously described (Mano
and Driscoll 2009; Tehrani et al. 2014; Del Rosario et al. 2015). Dying cells were identified as
vacuole like structures that indicated swollen cell bodies going through necrosis. Cell bodies going
through necrosis in the nerve ring were quantified across the four larval stages and the adult stage
of the worm. Approximately 90 worms were counted per life stage. Statistical analysis was done
using GraphPad Prism. Two-way ANOVA was conducted on all comparisons followed up with
appropriate post hoc analysis. For specific identification of dying neurons we matched the dying
neurons to known glr-1 –expressing neurons based on their cell body location and structure of
their processes, as previously described (Feldmann et al. 2019).

Behavioral Assays:
Locomotion assays (duration of spontaneous forward mobility) (Brockie 2006; Burbea et al. 2002)
and nose touch assays (Kaplan and Horvitz 1993; Hart et al. 1995) were performed blindly, in
independent trials.
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Subcellular fractionations, Co-Immunoprecipitation and Western Blot:
Membrane fractions were isolated from mixed population of worms of the following strains:
EG3361(PPK-1::GFP;GLR-1::RFP), IMN54 gras-1;PPK-1::GFP;GLR-1::RFP, IMN59 PPK1::GFP;GLR-1::RFP;Ex[Pglr-1Tam_PDZ;MEC-4::GFP], IMN60 gras-1;PPK-1::GFP;GLR1::RFP; Ex[Pglr-1Tam_PDZ;MEC-4::GFP]. Samples were prepared as described by the Juo lab
(Kowalski et al. 2011). Worms were rinsed off plates with water and then washed with M9
buffer. Worm pellet was than washed and frozen in Freezing buffer (50mM HEPES, pH 7.4, 1mM
EGTA, 1mM magnesium chloride, 100mM potassium chloride, and 10% glycerol). Frozen pellet
was thawed on ice and spun down to remove Freezing buffer. Pellet was gently dissolved in Buffer
A (50mM HEPES, pH 7.7 50mM potassium acetate, 2mM magnesium acetate, 250mM sucrose,
and 1mM EDTA), plus protease inhibitors (ThermoScientific Cat# 87786) and Zirconium Oxide
Beads (ZrOB05) and homogenized in Bullet blender (Next Advance SKU: BBX24) in 4 degree
Celsius. Samples were then spun down at 15,000 RPM for 15 min to remove worm carcass. To
separate membrane fraction, supernatant was spun down at 55,000 rpm in Beckman Ti100
rotor for 30min. Pellet was than resuspended in Buffer A plus protease inhibitors and 7mM ßmercaptoethanol. Immunoprecipitation (IP) were performed as described previously (Burbea et al.
2002; Kowalski et al. 2011). Samples were solubilized in SDS buffer (50mM Tris-Cl, pH 8.5, 1%
SDS, and 2mM DTT) and then diluted with 50mM HEPES, pH 7.7, 150mm NaCl, 1% NP-40 and
protease

inhibitors. Anti-GFP polyclonal antibody

(Novus Biologicals

Catalog

NB600308) and Protein A/G agarose beads (ThermoScientific Cat# 20421) were added and
mixed overnight at 4 degree Celcius to isolate PPK-1::GFP protein. Beads were washed with
50mM HEPES, pH 7.7, 150mM NaCl, 1% NP-40. PPK-1::GFP or GRAS-1::GFP was eluted with
SDS buffer at 95 degree Celsius for 5min. IP were analyzed by Western blot with monoclonal anti-
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GFP (Invitrogen MA515256), monoclonal anti-RFP (Invitrogen MA515257) and anti-beta-actin
(Novus Biological NB600501) followed by anti-mouse secondary (LI-COR C50512-02) and
detected with Odyssey CLx from LI-COR.

Microscopy and Imaging:
DAF-16::RFP localization was imaged using Nomarski DIC and fluorescence microscopy
(AxioZeiss) with the 63× objective. L3 animals were mounted on agarose gel pads (2%)
microscope slides with a drop of 10mM sodium azide (NaN3; Amresco CAS # 26628‐22‐8) added
to immobilize worms.

2.5.1 Supplementary Methods:
Worm Growing Protocol for IP & Western Blot:
a. Per strain: pick worms on to 20 large plates; placing 20-25 healthy adults
i. I like to place 3-5 worms on the “elbows” of the OP-50 spread on plates
b. Once plated are populated (about 5days depending on strain) collect the worms
i. Use ddH2O to flood the first plate (I use a glass pippet & add 8-10mL
ddH2O)
ii. Gently shake the plate to lift the worms
iii. Transfer the liquid from the first plate on to the next plate to continue
collecting worms
iv. Repeat B & C until worms from all plates from the strain are collected; add
ddH2O if the plate seems to be absorbing too much water.
v. Collect the liquid in a 50mL conical tube.
vi. After the first round of wash, Rinse the plates a second time
vii. Repeat steps A to E.
c. Spin the 50mL conical tub to precipitate the worms
i. Spin the worms at speed of 800G (RCF) for 1min
d. Remove the liquid careful not to disturb the pellet of worms.
e. Add 5mL of M9 to wash worms
i. Spin the worms again with M9 at speed 800G (RCF) for 1min
f. Add 2mL of M9 and carefully transfer the worms into 1.7mL Microcentrifuge tubes
g. Spin in centrifuge to collect worms.
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h. Collect no more than 300uL of worms per tube
i. Split worms of the same strain into multiple tubes
Homogenizing Protocol:
a.
b.
c.
d.
e.
f.

Add 250uL of Freezing buffer into each tube and mix gently.
Freeze the tubes of worms in -80oC for an hour to overnight
Thaw tubes of worms on ice
Once completely thawed spin tubes down at 800G for 1min
Remove liquid
Add equal volume of Zirconium Oxide Beads (ZrOB05)
i. Found in Li lab
g. Add 2 times the volume of Buffer A plus protease inhibitor
h. Place tubes in Bullet Homogenizer (located in walk-in 4o)
i. Run at speed 10 for 5min
i. Remove tubes from Bullet Homogenizer.
j. Spin tubes in Microcentrifuge at 15,000RPM for 15min at 4OC
k. Collect the homogenate; careful not to pick up worm carcass
Membrane Separation Protocol:
a. Contact Khayat Lab to use their Ultracentrifuge located on second floor.
i. Contact person: Maroun Diab maroundiab@hotmail.com
ii. Contact Person: Andres Ferrino: andresferrino@gmail.com
iii. Contact person (PI): Reza Khayat: rkhayat@ccny.cuny.edu
b. Make sure Ultracentrifuge is turned on and set to 4OC and Type Ti100 rotor placed
in 4OC
c. Place homogenate in Beckman Polypropylene tubes (Beckman 349623)
i. Make sure to balance the tubes using Emerson Lab weigh machine
d. Set Ultracentrifuge to 100,000G for 30min at 4OC.
i. If you are unsure on how to use the Ultracentrifuge than ask for help
e. Start the spin
f. After spin remove supernatant and save as the non-membrane fraction.
g. Resuspend pellet with 200uL of Buffer A plus Protease inhibitor plus 7mM βmercaptoethanol
h. Save 20uL as Membrane fraction. Use the rest for IP experiment.
IP Protocol:
a. Add 1 volume of SDS buffer to membrane fraction.
b. Dilute with 5 volume of Dilution Buffer plus protease inhibitor.
c. Add antibody and shake overnight in 4OC walk-in.
i. I use 1:200 ratio for antibody
d. Add A/G beads after 4hours (at the end of day)
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e.
f.
g.
h.
i.
j.

k.

i. For A/G beads: swirl bottle and remove 50uL and place in microcentrifuge
tube
ii. Wash beads with Dilution Buffer 3X by centrifugation at 1000G for 1min
iii. Remove liquid leaving 100uL
iv. Cut the tip of pippet tip and add A/G beads to the membrane fraction +
Antibody tube
Let shake overnight in 4OC walk-in
Next day spin down tubes at 2000G for 1 min at 4OC.
Save supernatant for western blot.
i. Supernatant contains all unbound protein
Wash beads 3X with 800uL of Wash Buffer each time.
i. Gently mix and spin down at 2000G for 1 min at 4OC to collect beads.
After final wash remove as much liquid as possible without disturbing beads.
Elute with 20uL ddH2O and 1X sample buffer.
i. I use stock 6x sample buffer and add 4uL of buffer to 20uL elution to dilute
to 1X sample buffer.
Boil samples in 95OC for 10min.
i. I add water to 95OC heating block to ensure samples have direct contact to
95OC.

Western Blot Protocol:
a. Make 10% SDS gels
i. Can be made beforehand and stored with a little fluid and wrapped in cling
on and stored in 4OC for later use.
b. Prepare all samples for loading.
i. Prepare appropriate controls such as: untreated Membrane fraction, Nonmembrane, Supernatant, A/G bead control, and any other controls.
1. A/G beads show several bands so need to run just beads to separate
bead bands from IP bands
c. Assemble the Western blot chamber
i. Place gels in the removal chamber with the front facing outward
ii. Replace chamber back in western blot apparatus
iii.
Fill the middle chamber with 1X running buffer
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d.

e.

f.
g.
h.
i.
j.
k.

l.
m.
n.

1. Diluted from 10X running buffer and diluted with ddH2O
iv.
Make sure liquid is not leaking from the bottom in the apparatus
1. If it is leaking, collect liquid back in graduated cylinder and
reassemble the middle chamber by readjusting the gels.
Once assembled you can remove the combs from the gels
i. Make sure liquid goes into the wells and you don’t have bubbles in them
1. If you get bubbles try to flush the wells with buffer.
Load samples into the wells of the gels.
i. Use long p10 tips to load wells
ii. Make sure to balance the gel so that the left and right side of the gel have
approximately weight distribution.
1. Otherwise the “heavier” side will pull samples to that side
2. Or you may get a “smiley” gel
iii.
To load the back gel I load from the front; not moving the apparatus
iv.
Make sure to load Protein ladder
v. Position of the ladder can used to differentiate between gels
Fill the outer chambers with the leftover running buffer.
Make sure to write down the order of the samples loaded
Put the lid on and connect to the power supply box
Run samples at 50V until samples run past the stacking gel (approximately 45min)
For the resolving gel portion I increase the voltage to 115-120V and run till the
samples run to the bottom (approximately 1hour)
While the gel is running I prep the 1X transfer buffer
i. I find 1.5L of 1X transfer buffer is sufficient to prep sandwich and for filling
the western blot apparatus.
ii. Recipe: 150mL of 10X transfer buffer + 300mL methanol + ddH2O to 1.5L
iii.
Apparatus hold approximately 1L
iv.
Use 500mL to assemble sandwich
v. Leftover 1X transfer buffer can be stored and used later
Store the prepped 1X transfer buffer on ice or in the 4OC walk-in
Once the gel is finished running (samples reach the
bottom), stop the machine!
Prepare the sandwich as shown below.
i. Crack open the gels using the green spatula
ii. Cut off the stacking gel portion
iii.
Be gentle not to tear the gel
iv.
I open the gel cast so that the gel will be
on the thinner side; this makes it easier to remove the gel
v. Fill a wide container with 1X transfer buffer and assemble the sandwich
submerged in buffer.
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vi.
Once the gel is on the thinner glass I remove the stacking gel and
invert the gel so the gel side touches the buffer and slowly try to wash it off
on top of the filter paper it need to be on for the sandwich

vii.
Image of assembly:
o.
p.
q.
r.
s.
t.
u.
v.

After assembly, fill the apparatus ¾ way with 1X transfer buffer
Add an ice pack in to the apparatus
Place a stir bar on the bottom and place the apparatus on top of a stir plate
Turn on the stir plate so that there is gentle circulation of the liquid.
Insert the sandwich into the red and black center chamber as shown to the right
Add more 1X transfer buffer if needed
Put on the lid and connect to power source
Run the transfer at 200mA for 1 hour OR overnight at 16mA for 16 hours in the
4OC walk-in
w. After transfer, you can Ponceau S stain the membrane to visualize the protein bands
(helpful if you plan on cutting the membrane or just to check that you have good
transfer without bubbles).
x. Rinse the Ponceau S stain off in water and place on a mat to cut the membrane
i. Label the edges of the membrane with a pencil for the different antibody
you will treat with a cut accordingly.
y. Place the membrane in blocker for at least one hour or overnight
z. Transfer the membrane to the primary antibody (Anti-GFP, anti-RFP and anti-betaactin)(diluted in extra blocking solution); shake for one hour or overnight in 4
degree.
aa. Wash the membrane blot 3X for 10 min in TBS-T.
bb. Transfer the membrane blot in secondary antibody (diluted in 3% milk or BSA)
(antibody against animal the primary antibody was raised in) for one hour shaking.
cc. Wash the membrane blot 3X for 10min in TBS-T.
dd. Image the blot using the Li-Cor machine on the second floor.
ee. All Done!
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2.6 Supplementary
2.6.1 PPK-1 localizes in GLR-1 expressing neurons
To examine whether the Cytohesin complex and the GLR-1 interact at a cellular level we
evaluated their co-localization by imaging. To conduct this experiment, we used a strain
expressing PPK-1 fused to GFP and GLR-1 fused to RFP, which would allow the visualization
of the protein and their localization. Imaging the head region of this strain showed the colocalization of PPK-1 and GLR-1. Thus, PPK-1 being a key component of the Cytohesin
complex, we found that the Cytohesin complex and the GLR-1 are found in the same cells and in
close proximity.

Figure S1:
PPK-1 localizes and physically interacts or complexes with GLR-1 under basal conditions. (A)
Fluorescent images of PPK-1::GFP and GLR-1::RFP show both localize together in the head
region of the worm. The localization between PPK-1 and GLR-1 does not change under
Tamalin/GRAS-1 KO compared to basal conditions. (B) Quantification of the localization
between PPK-1 and GLR-1 using Manders Co-localization coefficient show no significant
differences between basal and Tamalin/GRAS-1 KO conditions (t(10)=1.209, p=0.254). (C)
Interaction between PPK-1 and GLR-1 were evaluated by immunoprecipitation and western
blotting. Immunoprecipitation of PPK-1::GFP shows presence of GLR-1::RFP. Interaction
between PPK-1 and GLR-1 remains even in the absence of Tamalin/GRAS-1. The arrow
indicates the location of the GLR-1::RFP protein. n>8
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We next went on to evaluate whether the co-localization of PPK-1 and GLR-1 is dependent on
Tamalin. To conduct this experiment, we took the previous strain (PPK-1::GFP;GLR-1::RFP) and
crossed it with Tamalin/GRAS-1 KO strain (gras-1). We than imaged the new strain (gras-1;PPK1::GFP;GLR-1::RFP) for GFP and RFP. The results show that the co-localization between PPK-1
and GLR-1 did not vary (t(10)=1.209, p=0.254)(Fig 7). The co-localization of the strain were
quantified using ImageJ using Manders co-localization coefficient.

2.6.2 Physical interaction between PPK-1 and GLR-1 found
Although the co-localization data is useful in evaluating whether the Cyothesin complex and GLR1 localize at a cellular level, it does not exemplify a biochemical interaction. Thus,
immunoprecipitation was conducted. We took the same strain used for the co-localization
experiments (PPK-1::GFP;GLR-1::RFP and gras-1;PPK-1::GFP;GLR-1::RFP) and performed IP
by using GFP antibody to pull down PPK-1. We than performed western blot on the samples to
evaluate the presence of GLR-1 by using RFP antibody. We used the antibody and the weight to
confirm identity of the proteins. We compared the presence and intensity of GLR-1 in
Tamalin/GRAS-1 WT and KO strains. We did not find any differences of GLR-1 interaction with
PPK-1 in either of the strains (Fig S1). Thus, interaction of the Cytohesin complex and GLR-1
does not seem dependent on Tamalin.
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2.6.3 Neurodegeneration Levels Not affected by RFP Fusion to PDZ Domain
We wanted to address an alternative reason for the unexpected neurodegenerative effects seen
when only the PDZ domain of Tamalin/GRAS-1 is expressed (in the absence of endogenous
Tamalin). One possible source of artifacts is the fusion of the expressed PDZ domain to the RFP
protein. The PDZ domain is quite small in size, smaller than the RFP protein it is attached to in
these strains. Therefore, it can be suggested that the effect we see on neurodegeneration from the
PDZ domain is a result of its fusion to the larger protein that can lead it to adverse interactions. In
order to test this hypothesis, I constructed the same strain but with a free PDZ domain, unbound
to RFP (glt-3;nuIs5; Ex[Pglr-1::GRAS-1_PDZ;MEC-4::GFP], without or with gras-1 ko). Strains
were confirmed with the presence of the co-injection marker, MEC-4::GFP. I then quantified
neurodegeneration levels across the different life stages between the different strains with glt3;nuIs5 and gras-1;glt-3;nuIs5 as controls. The results as shown in figure S2 - demonstrate that
expression of the PDZ domain still reinstates neurodegeneration level to glt-3;nuIs5 in the absence
of

endogenous

Tamalin/GRAS-1

(F(12,585)=13.81,

p<0.0001).

Overexpression

of

Tamalin/GRAS-1 PDZ domain significantly increased neurodegeneration levels in the absence of
endogenous Tamalin/GRAS-1 in excitotoxic conditions compared to Tamalin/GRAS-1 KO
excitotoxic conditions at L2 (p=0.0003), L3 and L4 (p<0.0001). Thus, the fusion of the RFP
protein does not produce physiological changes in terms of neurodegeneration.
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Figure S2:
RFP fusion to the Tamalin/GRAS-1 PDZ domain did not influence the neurodegeneration levels
observed. Tamalin/GRAS-1 PDZ domain not fused to RFP were used to measure
neurodegeneration levels to ensure that fusion of the RFP protein did not influence the results of
the PDZ domain. An overall ANOVA of Interaction show significant differences between all the
strains across the different life stages (F(12,585)=13.81, p<0.0001). Post-hoc analysis show that
Tamalin/GRAS-1 PDZ domain in the absence of endogenous Tamalin/GRAS-1 in excitotoxic
conditions significantly increases neurodegeneration levels compared to Tamalin/GRAS-1 KO
excitotoxic conditions at L2 (p=0.0003), L3 and L4 stages (p<0.0001). n=65 *** indicates
p<0.001, **** indicates p<0.0001
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2.6.4 LIN-10 is a regulator of Neuroprotection but has opposing roles at later life stages
We further investigated to find an alternative scaffolding protein the Tamalin/GRAS-1 PDZ
domain is functioning through. We looked at the role of LIN-10 and whether it mediates
neuroprotection under excitotoxicity. Depending on the role of LIN-10 in excitotoxicity, we
would further investigate its role with the Tamalin/GRAS-1 PDZ domain. We constructed lin10;glt-3;nuIs5 and age-1;lin-10;glt-3;nuIs5 and compared them to glt-3;nuIs5 and age-1;glt3;nuIs5. Comparing all the strains we found that there were significant differences between the
strains across the different life stages (F(12,680)=38.24, p<0.0001). There were no significant
differences at L1 and L2 stages. We found that at L3 age-1;glt-3;nuIs5, lin-10;glt3;nuIs5 and age-1;lin-10;glt-3;nuIs5 was significantly lower in neurodegeneration compared
to glt-3;nuIs5 (p<0.0001). At L4, age-1;glt-3;nuIs5, lin-10;glt-3;nuIs5 and age-1;lin-10;glt3;nuIs5 was significantly lower in neurodegeneration compared to glt-3;nuIs5 (p<0.01). At
L4, age-1;glt-3;nuIs5 was significantly lower than lin-10;glt-3;nuIs5 and age-1;lin-10;glt3;nuIs5 (p<0.0001). At adult stage, lin-10;glt-3;nuIs5 was significantly higher in
neurodegeneration than glt-3;nuIs5 and age-1;glt-3;nuIs5 and lin-10;age-1;glt-3;nuIs5
(p<0.0001). The results from this experiment showed that LIN-10 has a bidirectional effect on
neurodegeneration in excitotoxicity with life stage. Thus, it does not seem likely that the
Tamalin/GRAS-1 PDZ domain affects neurodegeneration via LIN-10 since they do
not affect neurodegeneration in excitotoxicity similarly.
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Table 1: Description of significance seen in Figure S3
Significance
glt-3;nuIs5 vs
age-1;glt3;nuIs5
lin-10;glt-3;nuIs5
lin-10;age-1;glt-3;nuIs5
age-1;glt3;nuIs5
vs
lin-10;age-1;glt-3;nuIs5
glt-3;nuIs5 vs
lin-10;age-1;glt-3;nuIs5
lin-10;glt-3;nuIs5 vs lin-10;age-1;glt-3;nuIs5

Figure S3:
LIN-10 affects
neurodegeneration levels
independently of the
Insulin/IGF signaling
0.0001
L4
cascade. An overall ANOVA
shows significant differences
0.01
L4
between all the strains across
the different life stages
0.0001
Adult
(F(12,680)=38.24,
glt-3;nuIs5 vs lin-10;glt-3;nuIs5
0.0001
Adult
p<0.0001). Post-hoc Tukey
analysis show basal
excitotoxic condition to have significantly higher neurodegeneration levels compared to the other
strains at L3 (p<0.0001) and at L4 (p<0.01). LIN-10 KO in excitotoxic conditions had
significantly higher neurodegeneration levels at adult stage compared to basal excitotoxic
conditions (p<0.0001) and to LIN-10/AGE-1 KO in excitotoxic condition (p<0.001). At L4
stage AGE-1 KO in excitotoxic conditions had significantly reduced neurodegeneration level
compared to LIN-10 KO in excitotoxic condition and LIN-10/AGE-1 KO in excitotoxic
condition (p<0.0001). n>30 ** p<0.01, *** p<0.001, **** p<0.0001
p-value
0.0001
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Life stage
L3
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3.1 Abstract
Excitotoxicity is a common mechanism of neurodegeneration across many degenerative
diseases. The common assumption had previously been that the overactivation of GluR solely lead
to activation of neurodegenerative pathways. However, studies that blocked GluR activity under
excitotoxic conditions showed increased fatality, concluding that GluR activity under
excitotoxicity is necessary for neuroprotection. CREB, a neuroprotective transcription factor, had
previously been shown to be regulated by GluRs and an important regulator for neuroprotection.
However, the mechanism through which CREB is activated under such conditions is still to be
discovered. Using C. elegans as a model organism, a nematode excitotoxicity strain was created.
Using this model, we discovered that under excitotoxicity a non-canonical activation of CREB
mediates neuroprotection in excitotoxic necrosis. However, since transcription factors rarely
function alone, we examined a possible collaboration between CREB and DAF-16 in selecting
downstream targets. To test if activation of these transcription factors was through distinct
pathways, we conducted an epistatic analysis. Pharmacological and genetic analysis revealed that
CREB and DAF-16 work in separate parallel pathways that might converge to regulate similar
targets in excitotoxicity. Analysis of potential co-regulated genes of both CREB and DAF-16 is
ongoing and may result in therapeutic targets in excitotoxicity.
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3.2 Introduction
As discussed in Chapter 2, the localization of DAF-16 to the nucleus is necessary for the
mediation of neuroprotection in necrotic excitotoxicity. The Insulin/IGF Signaling (IIS) cascade
is an important regulator of neuroprotection in excitotoxicity and mediates these effects through
the regulation of transcription factor DAF-16 (Tehrani et al. 2014; Mojsilovic-Petrovic et
al. 2009). Activation of the IIS cascade leads to the activation of AKT that phosphorylates DAF16, inhibiting DAF-16 entrance into the nucleus to mitigate neuroprotection. Inhibition of IIS in
contrast, activates DAF-16 by allowing its nuclear localization.
Some studies have found that AKT, the final kinase in the IIS cascade, can directly
phosphorylate and lead to the activation of CREB (Du and Montminy 1998). Thus, it is not clear
whether CREB and DAF-16 work in a linear single pathway or are regulated by
independent excito-protective pathways. To test whether the neuroprotection mediated by IIS
cascade is dependent or independent of CREB, I performed pharmacological and genetic epistatic
analysis. This chapter does only contain the figures contributed by me to the Feldmann et al. 2019
paper.
3.2.1

Transcription factor CREB is an important modulator of neuroprotection in
excitotoxicity

CREB (Ca2+/cAMP

Response

Element

Binding

Protein)

is

a

Ca2+/cAMP

activated, bZip domain-containing transcription factor that is commonly activated by the binding
of cAMP Response Element (CRE) (Montminy et al. 1986; Montminy and Bilezikjian 1987).
CREB consists of several domains: Q1, Q2, Kinase-inducible domain (KID, also includes Ser133
residue) and a leucine zipper (bZip) domain (allows DNA binding and dimerization). The
activation of CREB was initially established to be by phosphorylation at S133 (Gonzalez and
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Montminy 1989). CREB has been found to be the target of several Ca2+/Calmodulin Dependent
Kinases (CaMKs) all targeting the S133 site. Once phosphorylated, P-CREB recruits CREB
binding Protein (CBP), a histone acetyltransferase that modifies histones and “relaxes” DNA
packaging allowing transcription (Chrivia et al. 1993).
CREB is a post-translationally activated transcription factor that has been implicated in
numerous different function (Walton et al. 1999) including long-term facilitation/learning and
memory (Dash et al. 1990; Sheng et al. 1990; Kandel 2001). CREB is the target of both calcium
and cAMP via multiple different pathways. Thus, CREB has been found to be involved in many
different conditions since it is activated by thousands of different known pathways (Walton et
al. 1999).
Walton 1999 was one of the first studies to link CREB activity with neuroprotection in a
hypoxia induced excitotoxicity model. Moderate and severe hypoxic-ischemia in the rat brain
was found to increase apoptosis. However, increased levels of CREB protein were found to
be sufficient to inhibit apoptosis (Walton et al. 1999), suggesting that CREB is a survival factor
for neuronal cells and may be neuroprotective. A later study found that in global ischemia, an
NMDAR antagonist diminished CREB phosphorylation, showcasing the necessity of extracellular
calcium to increase CREB phosphorylation (Mabuchi et al. 2001). These studies together show
the importance of CREB activation in neuroprotection and that Glu activity may be able to regulate
CREB phosphorylation. Since CREB can be activated by many different pathways it was
important to investigate the importance of GluR activated CREB to mitigate neuroprotection.
Thus, it was suggested that GluR antagonists increased neuronal damage due to reduced CREB
activation (Ikonomidou and Turski 2002).
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CREB-regulated genes under excitotoxicity have been identified and examined; however,
such experiments were done with focus on anti-apoptotic conditions. Though necrotic
excitotoxicity is the primary cause of neurodegeneration in the stroke’s core region (which
ultimately includes the transitory penumbra region), the role of CREB–mediated non-apoptotic
neuroprotection is understudied. Because the genes regulated by CREB is dependent on the
method through which CREB is activated, it is important to evaluate the pathway via which CREB
is activated under necrotic excitotoxic conditions.
Research from our lab has shown that in a necrotic model of excitotoxicity, CREB is
activated via a non-conical pathway and independent of phosphorylation (Feldmann et
al. 2019). The results from this study suggest that the specific mechanism of activation is important
to activate the particular transcriptional response necessary in necrotic excitotoxicity. However, to
control the expression of a more specific set of genes regulated for neuroprotection in necrotic
excitotoxicity, it is likely that CREB works together with other transcription factors to confer
specificity.
3.2.2

CREB and DAF-16 share common gene targets

Thus far, there has not been any analysis of FoxO/DAF-16 gene targets important in
excitotoxic neuroprotection. Previous transcriptome studies in the worm examined downstream
gene targets of DAF-16 (Kaletsky et al. 2016) and downstream gene target of CREB in short-term
associative memory and long-term associative memory (Lakhina et al. 2015; Freytag et al. 2017)
under non-pathological conditions Comparison of these lists of gene targets shows some overlap
between the two transcription factors. Examining this list of conserved gene targets, there are some
we suspect may be regulated and important for neuroprotection in excitotoxicity. The list of shared
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gene targets of DAF-16 and CREB include proteins involved in: calcium signaling, cell death,
fatty acid synthesis, and glutamine/glutamate signaling-related molecules.
Examination of the common downstream gene targets of DAF-16 and CREB, in
excitotoxicity, will help lead to gene targets necessary for neuroprotection against excitotoxicity.
Initial investigation into the common genes targeted by both DAF-16 and CREB have
been examined but will not be discussed in this chapter. This chapter will serve to examine whether
or not IIS cascade regulated neuroprotection independently of CREB activity.
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3.3 Results
3.3.1 CREB and DAF-16 work independently to collaborate neuroprotection
A number of studies have concluded that the IIS cascade indirectly regulates CREB. IIS
cascade activation was shown to activate AKT, which phosphorylates SIK2 which phosphorylates
CRTC, an activator of CREB (Berdeaux 2011; Altarejos et al. 2011; Wang et al. 2018). Thus, it
has been suggested that the neuroprotection regulated by IIS cascade is via CREB activity and not
FoxO/DAF-16. However, we hypothesize that the neuroprotection regulated by CREB and IIS
cascade is in parallel pathways. In order to test our hypothesis, we conducted an epistasis analysis
using a pharmacological and genetic approach. For the pharmacological examination we took our
CREB KO strain in excitotoxicity and treated it with the AGE-1 inhibitor LY294002 to reduce
overall IIS cascade activity. We than compared the treated strain with untreated CREB KO in
excitotoxicity with basal excitotoxicity strains. Comparing the neurodegeneration levels across the
different life stages we found that CREB KO in excitotoxicity significantly increased
neurodegeneration levels compared to basal excitotoxicity. Pharmacological inhibition of AGE-1
with a CREB KO excitotoxicity background significantly reduced neurodegeneration levels
compared to CREB KO excitotoxicity.
Using the genetic approach, we combined CREB KO with AGE-1 mutation in
excitotoxicity and compared it with CREB KO in excitotoxicity, AGE-1 mutant in excitotoxicity,
and basal excitotoxicity. ANOVA of interaction analysis shows significant differences between
the strains across the different life stages (F(12, 712)=18.44, p<0.0001). Post-hoc
analysis shows CRH-1

KO

in

excitotoxic

conditions

to

have

significantly

higher

neurodegeneration level compared to the other strains at all life stages (p<0.01-0.0001). AGE-1
KO in excitotoxic conditions significantly reduced neurodegeneration levels compared to basal
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excitotoxic conditions and CRH-1 KO in excitotoxic conditions at L1 (p<0.001), L2 (p<0.0001),
L3 (p<0.0001), L4 (p<0.0001) and adult stage (p<0.0001). Epistasis analysis with CRH-1 and
AGE-1 KO in excitotoxic conditions show significant differences from AGE-1 KO in excitotoxic
conditions and CRH-1 KO in excitotoxic conditions at L1 (p<0.01), L2 (p<0.0001), L3
(p<0.0001), L4 (p<0.0001) and adult stage (p<0.001-0.0001).
Results from the pharmacological and genetic approaches both show that even without the
presence of CREB, IIS cascade can still regulate neuroprotection. Thus, these results suggest that
IIS cascade regulates neuroprotection independent of CREB and is possibly solely through
regulation of DAF-16.

Figure 22:
CREB/CRH-1 and IIS cascade work independently to regulate neurodegeneration. ANOVA of
interaction analysis shows significant differences between the strains across the different life
stages (F(12, 712)=18.44, p<0.0001). Post-hoc Tukey analysis show CRH-1 KO in excitotoxic
conditions to have significantly higher neurodegeneration level compared to the other strains at
all life stages (p<0.01-0.0001). AGE-1 KO in excitotoxic conditions significantly reduced
neurodegeneration levels compared to basal excitotoxic conditions and CRH-1 KO in excitotoxic
conditions at L1 (p<0.001), L2 (p<0.0001), L3 (p<0.0001), L4 (p<0.0001) and adult stage
(p<0.0001). Epistasis analysis with CRH-1 and AGE-1 KO in excitotoxic conditions show
significant differences from AGE-1 KO in excitotoxic conditions and CRH-1 KO in excitotoxic
conditions at L1 (p<0.01), L2 (p<0.0001), L3 (p<0.0001), L4 (p<0.0001) and adult stage
(p<0.001-0.0001). ** p<0.01, *** p<0.001, **** p<0.0001
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3.4 Conclusions
The results from the Feldmann et al. (2019) paper showed that CREB is an important
transcription factor for regulating neuroprotection under excitotoxicity. Furthermore, it was found
that neuroprotection under excitotoxicity is regulated by CREB via a non-canonical mechanism.
Thus, the findings suggest that a unique transcriptional response is initiated by CREB due to the
specific method of CREB activation under excitotoxicity. In order to further narrow down our
downstream gene target important for neuroprotection under excitotoxicity, we investigated the
gene targets of both CREB and DAF-16 under excitotoxicity.
The previous chapter discussed the importance of DAF-16 localization to the nucleus as a
factor of neuroprotection under excitotoxicity. Tehrani et al. (2014) established that the IIS cascade
is a regulator of neuroprotection under excitotoxicity and suggested that it was due to the
downstream regulation of DAF-16. Chapter 2 of this thesis showed the DAF-16 nuclear
localization under basal excitotoxicity and Tamalin/GRAS-1 KO. The results of those experiments
showed that DAF-16 is found to be localized in some GLR-1 excitotoxic neurons that are not dying
in basal excitotoxicity. Furthermore, the level of DAF-16 localized to the nucleus was found to be
increased in more neuroprotective conditions (i. e. Tamalin/GRAS-1 ko strains). These results
combined together recognize that transcription factor DAF-16 is regulated by Tamalin/GRAS-1IIS cascade under excitotoxicity. Therefore, the unique set of genes transcribed by DAF-16 under
excitotoxicity is an important contributor of neuroprotection.
To isolate the most important gene targets necessary for regulating neuroprotection under
excitotoxicity, we next looked at the combined effects of CREB and DAF-16. We hypothesized
that CREB and DAF-16 are independently activated transcription factors that work together to
activate a unique set of genes important for neuroprotection specifically in excitotoxicity.
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The experiments contributed to the Feldmann et al. (2019) paper validated that IIS cascade
works independently of CREB activity to regulate neuroprotection. Previous papers had shown
that AKT of the IIS cascade can activate CREB, thus suggesting that neuroprotection mediated by
the IIS cascade is solely dependent on CREB activity. To test this notion, we looked at
neurodegeneration level under excitotoxicity in the absence of CREB. As expected absence of
CREB significantly increased neurodegeneration. However, inhibition of the IIS cascade, which
has previously been shown to be neuroprotective (Tehrani et al. 2014), significantly reduced
neurodegeneration levels even in the absence of CREB/CRH-1. Thus, the neuroprotection
regulated by IIS cascade can be concluded to be mediated independently of CREB
activity. Furthermore, the experiments were key in supporting the notion of examining the gene
targets of CREB and DAF-16 as they are transcription factors activated independently of one
another under excitotoxicity. Since both CREB and DAF-16 can be activated under many different
conditions, we can isolate the genes most important for neuroprotection by examining genes
regulated by both CREB and DAF-16 under the same excitotoxic condition.
The results also validate the importance of further examination of shared downstream
targets of both CREB and DAF-16, as those maybe key regulators of neuroprotection under
excitotoxicity. Currently, known shared gene targets of CREB and DAF-16, from previous papers,
with important biological implications are being further investigated to evaluate their roles in
excitotoxicity.
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3.5 Material & Methods
Crosses:
Strain age-1(hx546) and crh-1 received from CGC. Excitotoxicity strain: ZB1102: glt-3(bz34) IV;
nuIs5 V(RRID:CGC_ZB1102) (Mano and Driscoll 2009). Strains made for this paper: age-1;glt3;nuIs5, and age-1;crh-1;glt-3;nuIs5.
Strain Maintenance:
Strains were maintained at 20°C according to Brenner (Brenner 1974) and grown on MYOB agar
plates (Church et al. 1995) seeded with OP50 (Stiernagle 2006).
Pharmacological Inhibition of AGE-1
Inhibition of the insulin signaling pathway was achieved using 10mM LY294002 (Sigma)
dissolved in ethanol and plated on 6-well plates filled with agar; protocol was carried out according
to Tehrani et al. (2014). Each strain was treated with ethanol as control. Exposure to ethanol alone
decreased levels of neurodegeneration for unknown mechanistic reasons.
Quantification of Neurodegeneration:
Neurodegeneration was counted in the head and tail of the worm. Dying cells were identified as
vacuole like structures that indicated swollen cell bodies going through necrosis. Cell bodies going
through necrosis in the nerve ring were quantified across the four larval stages and the adult stage
of the worm. Approximately 90 worms were counted per life stage. Statistical analysis was done
using GraphPad Prism. Two-way ANOVA was conducted on all comparisons followed up with
appropriate post hoc analysis.
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Chapter 4
Conclusions and Future Directions
4.1 Conclusions
My PhD thesis has been a journey to establish an alternative pathway through
which GluRs can regulate neuroprotection under excitotoxicity. We hypothesized a link between
the activity of the insulin signaling cascade with GluR signaling. We knew from experiments done
in the lab that the IIS cascade is an important regulator of neuroprotection under nematode
excitotoxicity

(Tehrani et

al. 2014;

Mojsilovic-Petrovic et

al. 2009)

and

in

other

neurodegenerative conditions (Lioutas et al. 2015; Cohen and Dillin 2008; Kolanus 2007). Thus,
we

investigated

the

role

of

a

scaffolding

protein,

Tamalin,

shown

to

interact

with GluRs and Cytohesin, an upstream regulator of IIS cascade.
As discussed in chapter 2, Tamalin/GRAS-1 was found to be important for regulating
neuroprotection in excitotoxicity. We first characterized the expression of Tamalin/GRAS-1 and
found it be expressed in many neurons. Most importantly for us, Tamalin/GRAS-1 was found to
be expressed also in GLR-1 expressing neurons and more crucially found to be bound to GLR-1
in basal conditions. Thus, these results showed that Tamalin/GRAS-1 has a direct or indirect
physical interaction with GLR-1. We than checked if the Cytohesin complex, an upstream
regulator of the IIS cascade (Tehrani et al. 2014; Li et al. 2012; Estevez et al. 2014; Zhai et
al. 2015; Nie and Randazzo 2006; Kahn et al. 2005; Kahn et al. 2006; Hafner et al. 2006; Fuss et
al. 2006), complexes with GLR-1 and whether that binding is dependent on the presence of
Tamalin/GRAS-1. Results showed that Cytohesin complexes with GLR-1 but that physical
interaction is not dependent on the presence of Tamalin/GRAS-1. However, the postsynaptic
density is built on complex interactions and the overall integrity of the complex may not
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necessarily be dependent on the association between only two proteins (Kim and Sheng 2004).
The results from these interaction assays showcase that there is interaction between GLR-1,
Tamalin/GRAS-1 and regulators of the IIS cascade. Thus, Tamalin/GRAS-1 may have
physiological implications in excitotoxic conditions.
Our next experiments sought to evaluate whether Tamalin/GRAS-1 has any physiological
effects on neurodegeneration under excitotoxicity. We found that Tamalin/GRAS-1 removal
significantly reduced neurodegeneration in excitotoxic condition. We than investigated whether
the reduction in neurodegeneration was a result of Tamalin/GRAS-1 regulating IIS cascade.
Epistasis analysis with inhibition of Tamalin/GRAS-1 and the IIS cascade revealed that
Tamalin/GRAS-1 does in fact mediate neuroprotection via the IIS cascade. We also show that the
decrease in neurodegeneration mediated by Tamalin/GRAS-1 or the IIS cascade is not due to its
upstream regulation of GLR-1, as found in some mammalian studies. Our results show that
decrease in neurodegeneration is from a downstream effect targeted by the IIS cascade.
We than evaluated the effect of Tamalin/GRAS-1 rescue and overexpression in GLR-1
expressing neurons. The goal was to check whether Tamalin/GRAS-1 works cell autonomously to
mediate its effects in excitotoxic neurodegeneration and whether overexpression of
Tamalin/GRAS-1 is able to exacerbate the neurodegenerative effects. We found that rescue of
Tamalin/GRAS-1 in just GLR-1 neurons was sufficient to reestablish the neurodegenerative
effects as endogenous Tamalin/GRAS-1 expression. Thus, Tamalin/GRAS-1 seems to be
mediating the neuroprotective effects within GLR-1 expressing neurons. Furthermore,
overexpression of Tamalin/GRAS-1 did not show much difference, meaning Tamalin/GRAS-1
overexpression did not exacerbate neurodegeneration. This can suggest that Tamalin/GRAS-1 has
a singular role in the neuroprotective pathway under excitotoxicity.
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Since Tamalin/GRAS-1 is a multidomain protein (Kitano et al. 2002; Nevrivy et al. 2000;
Ogawa et al. 2007; Sugi et al. 2007), we evaluated the importance of the PDZ domain and the
leucine zipper domain interactions in excitotoxicity. Our goal was to see if we are able to isolate
the interactions Tamalin/GRAS-1 has with GLR-1 and the IIS cascade to affect the physiological
effects in neurodegeneration. By overexpressing the PDZ domain we hoped to inhibit the
interaction of endogenous Tamalin/GRAS-1 and reduce the excitotoxic signal it receives. We
found overexpression of PDZ domain without endogenous Tamalin/GRAS-1 was sufficient to
reinstate the level of neurodegeneration seem with full length Tamalin/GRAS-1. These results
were surprising and suggested that the overexpression of the PDZ domain may affect other nontargeted interactions to be taking place and the neurodegenerative effects seem maybe mediated
by interactions with other scaffolding proteins.
Other scaffolding proteins with PDZ domain include LIN-2, LIN-7 and LIN-10 that have
been shown to be involved in diverse mechanisms underlying neuronal activity and
function (Rongo et al. 1998; Bredt 1998; Sheng and Sala 2001; Kitano et al. 2003; Glodowski et
al. 2005; Feng and Zhang 2009). However, our studies showed that LIN-10 may not be involved
in regulating neuroprotection under excitotoxicity working via the IIS cascade. Another such
protein that may be involved in our complex is PTEN, phosphatase and tensin homolog. PTEN
indirectly inhibits AKT activity (Shabanzadeh et al. 2019; Christensen et al. 2011), thus reducing
overall IIS cascade activity and possibly increases neuroprotection in such matter. PTEN
recruitment promotes neuron survival, regeneration and functional recovery after CNS
injury (Shabanzadeh et al. 2019; Christensen et al. 2011). Thus, since PTEN can regulate
neuroprotection via the IIS cascade and functions through a C-terminal PDZ interactions, it is
possible that PTEN works in the complex involving GLR-1 and Tamalin/GRAS-1 to
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regulate neuroprotection. The overexpression of Tamalin/GRAS-1 PDZ domain may be able to
inhibit interaction of PTEN PDZ interactions with AKT to overall reduction of the neuroprotection
mediated by IIS cascade even with the absence of endogenous Tamalin/GRAS-1. CNK1,
connector enhancer of KSR 1, is a scaffolding protein member of the Cytohesin family and is
crucial for the activation of AKT (Lim et al. 2010). Thus, CNK1 is another possible scaffolding
protein that may also have role in regulating neuroprotection in our model of excitotoxicity.
For the Leucine zipper domain, we also proposed that overexpression of this domain would
interfere with endogenous Tamalin/GRAS-1. The results show that overexpression of the leucine
zipper domain with endogenous Tamalin/GRAS-1 slightly reduced neurodegenerative effects.
Thus, it does seem that our hypothesis for this is true that the leucine zipper domain is inhibiting
endogenous Tamalin/GRAS-1 interaction with GLR-1. Our results showed Leucine Zipper
domain to have a significant affect at most life stages except L3, the life stage we usually see the
highest level of neurodegenerative changes. It is possible that Tamalin/GRAS-1 endogenous
expression is regulated differently when GluRs are fully active. We propose that the high level of
activity at L3 stage leads to endogenous Tamalin/GRAS-1 to be more bound to IIS cascade.
Therefore, at L3, the overexpression of Leucine Zipper under excitotoxicity is not sufficient to
break apart the activity of endogenous Tamalin/GRAS-1 to the Cytohesin complex to reduce
activity of IIS cascade. We also propose that the differences we see between the effects the PDZ
and the leucine zipper domain was maybe due to their localization. Evaluation of their fluorescent
images show PDZ domain to be widely expressed and the leucine zipper domain to be much more
localized, possibly in lysosomes sent for degradation.
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Figure 23: Summary of functional relation between GluRs, Tamalin/GRAS-1 and the Cytohesin
complex.
Backtracking to the neuroprotective effects we found regulated by Tamalin/GRAS-1, we
also quantified which GLR-1 neurons were most affected. Therefore, we quantified which GLR-1
neurons were dying under basal excitotoxicity and Tamalin/GRAS-1 ko excitotoxicity. When
categorized we found the sensory and mostly motor neurons were protected with Tamalin/GRAS1 KO. Thus, it seems the neuroprotection mediated by Tamalin/GRAS-1 is mostly taking effect in
motor and some sensory neurons. We further found that under excitotoxicity, live interneurons and
some live motor neurons were likely to have DAF-16 localized to the nucleus. Thus, it seems that
even under excitotoxicity there is protection of interneurons by DAF-16 nuclear localization. It is
possible that Tamalin/GRAS-1 mutation under excitotoxicity further pushes DAF-16 to the
nucleus of motor neurons, lowering the number of motor neurons we see dying. It is currently
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unclear why DAF-16’s movement to the nucleus is more robust in motor-neurons compared to
interneurons.
We then looked downstream to ensure that the neuroprotection being mediated by
Tamalin/GRAS-1 was in fact from the regulation of transcription factor DAF-16, as it is by IIS
cascade. We found that excitotoxicity was sufficient to localize DAF-16 to the nucleus in some
neurons. This was a major finding that establishes: 1) neuroprotection is mediated in
excitotoxicity; 2) the regulation of the IIS cascade seems to be an important factor in determining
the level of neuroprotection; and 3) GLR-1 activity can mediate neuroprotection via regulation of
DAF-16. Furthermore, we found Tamalin/GRAS-1 inhibition further localized DAF-16 to the
nucleus, which would imply that the neuroprotective effects of Tamalin/GRAS-1 is in direct
relation to its regulation of DAF-16 (Figure 24 and 25).

Figure 24: Summary of functional relation between Tamalin/GRAS-1 and the IIS cascade.
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The conclusion of this study showcases that the neuroprotection regulated in excitotoxicity
is independently regulated by DAF-16 and CREB. Both transcription factors can be linked back
to GLR-1 activity in excitotoxicity and found to be activated by separate pathways. These findings
showcase the importance of studying the gene targets of both DAF-16 and CREB under excitotoxic
conditions to discover similar targets of both that may have exceptional effects in neuroprotection.
The findings from this study should help to further the understanding of neuroprotection mediated
in excitotoxicity and lead to discovery of important factors involved in neuroprotection.

Figure 25: Working model diagram. Under basal conditions, GluRs activate Tamlain/GRAS-1,
which increases IIS cascade activity and decreases DAF-16 nuclear localization. Under
excitotoxicity, GluRs inactive Tamalin/GRAS-1, reducing IIS cascade and increasing DAF-16
localization to the nucleus.
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4.2 Future Experiments
The results from the current study demonstrates the importance of studying the downstream
gene targets activated by DAF-16 under excitotoxicity. Transcriptome analysis of DAF-16 under
physiological conditions has been conducted in a C. elegans model (Kaletsky et al. 2016). The
information from this study as revealed many possible DAF-16 gene targets that may be involved
in regulating neuroprotection in our nematode excitotoxicity model. Currently the role of one such
target, SOD-2/3, is being evaluated under excitotoxicity. SOD-2/3, superoxide dismutase,
transforms superoxides produced by the mitochondria to less toxic hydrogen and oxygen, allowing
the clearance of reactive oxygen species (ROS) and confering protection against cell
death (Wang et al. 2018). Mitochondrial function has been linked with IIS cascade and DAF-16
activity and may be an important factor in neuroprotection (Dillin 2002; Engelman et al. 2006;
Sadagurski and White 2013; Lakhina et al. 2019; Yuzefovych et al. 2010; Ogg et al. 1997;
Byrne et al. 2019; Moehle et al. 2019; Zhang et al. 2019; Wang et al. 2019). Our lab has found
that mitochondrial function is an important factor in neuroprotection regulated in excitotoxicity.
Thus, it may be that the neuroprotection regulated by Tamalin/GRAS-1 on DAF-16 is due to
mitochondrial function, as carried out by SOD-2/3.
Future experiments will conduct RNA sequence analysis on GLR-1 neurons in
excitotoxicity and compared to excito-neuroprotective (DAF-16 nuclear localized) and excitoneurodegenerative (CREB KO excitotoxicity). Comparison of the RNA seq data will elicit the
shared targets of DAF-16 and CREB and help to find more targets that maybe involved in
neuroprotection. The end goal is to fund novel therapeutic targets that will increase
neuroprotection in stroke and other neurodegenerative disorders.
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